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ABSTRACT
Neurogenic Orthostatic Hypotension (NOH) is a cardinal feature of autonomic failure. Patients
with NOH experience a persistent and consistent drop in blood pressure when standing due to
failure of the autonomic nervous system to reflexively increase sympathetic outflow. NOH
affects individuals worldwide, presenting as both a primary feature (i.e. Multiple Systems
Atrophy, Pure Autonomic Failure) and secondary to several common disorders including
diabetes and Parkinson’s Disease. However, there are still several gaps in our overall
understanding and assessment of patients with NOH. Therefore, the six studies presented in this
thesis aimed to address some of these gaps in our current knowledge.
Study 1 and 2 aimed to investigate activity within the central autonomic network (CAN) both at
rest and during standardized autonomic challenges to determine whether patients have reduced
activity relative to healthy controls. In this study we found patients had reduced activation in
several CAN structures including the cingulate cortices, thalamus, hippocampus and cerebellum.
Based on study 1 and 2 results, study 3 and 4 aimed to determine whether patients also had
reduced functional connectivity in two structures involved in postural blood pressure regulation:
the brainstem and cerebellum. We found patients had significantly less connectivity between the
brainstem and several CAN structures including the cerebellum, insula and cingulate cortices.
Additionally, patients had significantly less intracerebellar connectivity, less cerebellarbrainstem connectivity and reduced connectivity to CAN structures including the insula, anterior
cingulate, hippocampus, thalamus and putamen.
Finally, symptoms associated with NOH include postural light-headedness, dizziness and
syncope. Proper diagnosis rests in the ability to accurately distinguish these non-specific
symptoms as either orthostatic (postural) or non-orthostatic (non-postural). The purposes of
studies 5 and 6 were to create a simple instrument capable of making this distinction,
demonstrate its validity and reliability, sensitivity and specificity, and to test its ability to assess
individuals based on symptomatology. In these studies, I found our questionnaire was valid,
reliable and capable of positively predicting individuals with orthostatic intolerance related to
autonomic dysfunction.
ii

Overall, this thesis greatly expands our understanding of NOH pathophysiology and provides a
new tool for assessing orthostatic symptomatology related to autonomic dysfunction.
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SUMMARY FOR LAY AUDIENCE
The autonomic nervous system (ANS) is a branch of the nervous system that regulates processes
that occur without conscious effort, including: heart rate, breathing, blood pressure, sweating,
digestion, sexual function, respiration, urination and defecation. The ANS has two major
divisions: the sympathetic nervous system, primarily active during the “fight-or-flight” response,
and the parasympathetic nervous system, primarily active during “rest-and-digest”.
When we stand up, the ANS ensures gravity does not pull our blood into our legs. However,
when the ANS fails, this function is lost and as a result, individuals experience a significant drop
in blood pressure when standing. ANS failure affects individuals worldwide, presenting as both a
primary disorder (i.e. Pure Autonomic Failure) and secondary to several common disorders
including diabetes and Parkinson’s Disease. However, there are still several gaps in our overall
understanding and assessment of patients with autonomic failure. This thesis aimed to address
these gaps.
The first half of the thesis focused to improve our understanding of autonomic failure by
investigating brain activity in structures known to contribute to proper autonomic control. In
addition, I investigated how these brain regions may be functionally connected to help regulate
heart rate and blood pressure. I found patients with autonomic failure showed reduced activity in
several brain structures involved in blood pressure regulation and these structures showed
reduced functional connectivity among each other.
The second half of the thesis aimed to improve the assessment of patients with ANS failure.
When patients experience a significant blood pressure drop while standing, common symptoms
include light-headedness and dizziness. Proper diagnosis rests in the ability to accurately
distinguish these non-specific symptoms as either postural or non-postural. To identify and
assess patients, we created a questionnaire capable of making this distinction. I evaluated several
important parameters and found the questionnaire to be valid, reliable and capable of positively
predicting individuals with autonomic dysfunction based on a symptom assessment.
This thesis greatly expands our understanding of autonomic failure and provides a new tool for
assessing symptomatology related to autonomic dysfunction.
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CHAPTER 1

1

General Introduction
The idea that the body exists as two distinct systems, an “animal” (somatic) and an

“organic” (autonomic) originated with the ancient Greeks1. However, it would be Galen and
Vesalius who would be among the first to probe into the true nature of this division. In an
attempt to understand and characterize the complex neural network that is the Autonomic
Nervous System (ANS), the next several hundred years would see the rise and fall of theories
and descriptions put forth by Willis, Whytt, Bichat and others throughout the 17th, 18th, and
19th centuries1. Finally, in the 19th C Gaskell would develop the term “involuntary nervous
system” and, along with J.N. Langley, discern that two sets of fibers, with opposite effects,
supply each tissue. Eventually, Langley coined the term "autonomic" nervous system and
classified this system into “sympathetic” and “parasympathetic” divisions2.
Despite the enormous contributions that have brought us to our current understanding of
autonomic anatomy and physiology, many aspects of this complex system remain to be fully
elucidated. Among the current gaps in our knowledge is that regarding the causes and
consequences of autonomic failure. It is without question that a deeper understanding of diseases
of the ANS could lead to improved diagnostic evaluations, treatments and management and
improved understanding of basic pathophysiology contributing to ANS impairments.

1.1

The Autonomic Nervous System

The Autonomic Nervous System (ANS) is highly integrated with virtually all organs and systems
of the human body. The ANS functions autonomously i.e. without conscious effort, to regulate
many internal processes including, but not limited to, heart rate, breathing, blood pressure,
sweating, digestion, sexual function, respiration, urination and defecation. The ANS has two
major complementary subdivisions; the sympathetic nervous system is primarily active during
the “fight-or-flight” response, while the parasympathetic (vagal) nervous system is primarily
active during periods of “rest-and-digest”.

2

1.2

The Brainstem

The arterial baroreflex provides beat-to-beat control of arterial blood pressure at rest and
especially in response to postural changes. The brainstem contains clusters of nuclei that
maintain reflex control of blood pressure, total peripheral resistance and cardiac output. These
regions include the periaqueductal gray (PAG) in the midbrain, the parabrachial nucleus (PBN)
in the pons and several medullary sites such as the nucleus tractus solitarius (NTS) and
caudal/rostral portions of the ventrolateral medulla (CVLM and RVLM, respectively). A
considerable amount of work has established these brainstem regions and their associated
circuitry in cardiovascular autonomic control of the arterial baroreflex. The PBN serves as a
major relay center for afferent information to subcortical sites, including the hypothalamus,
thalamus and amygdala. The NTS is the primary site to receive afferent information, which is
then relayed, either directly or indirectly, through the PBN to rostral brainstem sites or forebrain
regions. Additionally, the NTS is the primary relay for medullary reflexes such as the arterial
baroreflex, chemoreflex and mechanoreflexes. The RVLM is integral for blood pressure
regulation. The RVLM provides tonic sympatho-excitation to sympathetic preganglionic neurons
in the intermediolateral cell column, which synapse with post-ganglionic axons to provide
peripheral sympathetic innervation to the heart and blood vessels to increase cardiac output and
total peripheral resistance3,4. The RVLM also receives modulatory inputs from brainstem nuclei
including inhibitory baroreceptor signals from the NTS and CVLM, as well as forebrain
regions5, such as the hypothalamus. The CVLM maintains tonic gamma aminobutyric acid
(GABA)-ergic inhibition of the RVLM and relays the arterial baroreflex sympatho-inhibitory
inputs from the NTS.

1.3

Peripheral Network

Peripheral control of autonomic responses is primarily regulated by the sympathetic and
parasympathetic systems. Both branches consist of preganglionic neurons located in the
brainstem or spinal cord that synapse with autonomic ganglia prior to innervating target organs.
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1.3.1

Sympathetic Nervous System

Most pre-ganglionic neurons of the sympathetic nervous system occupy the intermediolateral
cell (IML) column expanding the thoracolumbar spine from T1-L3. Short preganglionic
sympathetic axons enter the paravertebral ganglia (sympathetic chain ganglia) found on either
side of the spinal cord. Pre-ganglionic fibers can either stay at the same level or travel up or
down the chain. They synapse with post-ganglionic cell bodies and leave as long post-ganglionic
sympathetic fibers to their target tissue. Sympathetic chain ganglia innervate all organs and
tissues, except those of the abdomen, pelvis and perineum. Alternatively, some pre-ganglionic
fibers synapse in the prevertebral ganglia, which provides innervation to all viscera and blood
vessels of the abdomen and pelvis. The celiac and superior mesenteric ganglia receive inputs
from T5-T11, which provides innervation to abdominal viscera along with mesenteric and renal
vessels. Sympathetic innervation to pelvic organs originates from T11-L3. Pre-ganglionic axons
synapse with inferior mesenteric ganglia, which give rise to post-ganglionic neurons6.

1.3.2

Parasympathetic Nervous System

The most important cranial preganglionic axon of the parasympathetic nervous system is carried
by the vagus nerve. The vagus nerve innervates the heart, respiratory tract, gastrointestinal tract,
liver, pancreas and gallbladder6. Parasympathetic pre-ganglionic axons are long, release
acetylcholine (ACh) and synapse with ganglia close to the target tissue. Most vagal preganglionic axons originate from neurons within the dorsal motor nucleus of the vagus within the
medulla. These axons innervate the respiratory tract, esophagus, stomach and intestines. Preganglionic innervation to the heart primarily originates from the nucleus ambiguus in the
medulla6. Alternatively, sacral parasympathetic outflow originates from the sacral
parasympathetic nucleus of the spinal cord (S2-S4). Sacral parasympathetic outflow controls
defecation, micturition and sexual organ function6.
Together, the parasympathetic and sympathetic systems, along with arterial baroreceptor nuclei
within the brainstem facilitate a coordinated response to ensure autonomic homeostasis. Even a
task as simple as standing results in remarkably coordinated and intricate responses to maintain
postural normotension.
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1.4

Maintenance of Postural Normotension

When we stand up the pull of gravity causes an estimated 500-1000 mL redistribution of blood to
the lower extremities7. In healthy adults, ~50% of this shift occurs within the first 10 seconds and
is almost complete within 3-5 minutes of an orthostatic stress. Most of the pooled blood is
contained within the deep veins of the legs and splanchnic capacitance beds. Blood pooling plus
reduced plasma volume results in decreased venous return, reduced stroke volume and a
subsequent fall in cardiac output (~20%). Despite a reduction in cardiac output, a drop in arterial
blood pressure is prevented by compensatory vasoconstriction of the resistance and capacitance
vessels in the splanchnic, musculo-cutaneous and renal vascular beds. Mechanistically, when
there is a transient reduction in arterial blood pressure, reduced afferent inputs to cardiovascular
segments within the caudal NTS results in disinhibition of the RVLM, which in turn, results in a
reflexive increase in sympathetic efferent activity to the heart and vasculature to increase cardiac
output and total peripheral resistance, respectively. In contrast, during hypertension, increased
baroreceptor firing sends afferent information to the NTS. This information is relayed to the
nucleus ambiguus and/or the dorsal motor nucleus of the vagus to elicit direct parasympathetic
outflow. Additionally, afferent baroreceptor information is relayed to the CVLM, to facilitate
inhibitory modulation of the RVLM.

1.5

The Central Autonomic Network

In addition to afferent inputs, baroreceptor brainstem nuclei receive efferent signals from cortical
and subcortical structures. Benarroch (1993) was the first to propose an integrated model of
cortical, subcortical and brainstem structures involved in regulating autonomic function, known
as the central autonomic network (CAN)8. The concept of a central autonomic network has been
further corroborated through recent advances in neuroimaging, specifically, functional magnetic
resonance imaging (fMRI). As a result, several cortical and subcortical regions such as the
cingulate cortex, insula, hypothalamus, thalamus and cerebellum, have been highly implicated in
autonomic regulation. Although there are several important cortical and subcortical structures
that make up the CAN, here I will further discuss the insula (Figure 1.1), cingulate (Figure 1.2)
and cerebellum (Figure 1.3) as they are highly prevalent in autonomic literature.
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1.5.1

Insular Cortex

Anatomically, the insula has reciprocal projections to brainstem autonomic nuclei3,9, which
provides an anatomical basis for autonomic regulation. Functionally, the insula is extremely
complex. The insula can be structurally and functionally partitioned into anterior and posterior
portions as well as lateralized into left and right. For example, stimulation of the rostral posterior
insula in rats induced tachycardia while bradycardia was elicited via caudal stimulation10.
Furthermore, Zhang et al., (1998) demonstrated that damage to the left insula increased cardiac
baroreceptor gain with no effect on heart rate or blood pressure, while right insular lesions
caused increased baseline heart rate and blood pressure with no effect on gain11. Finally,
neuroimaging studies involving humans support insular activation in response to sympathoexcitatory tasks such as Valsalva, handgrip, maximal inspirations and lower-body negative
pressure12–14 (Figure 1.1). fMRI with simultaneous peripheral sympathetic recordings also
showed increased anterior insular activity corresponded with increase muscle sympathetic nerve
activity14,15.

Figure 1.1. Insula Cortex
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1.5.2

Cingulate Cortex

Similar to the insula cortex, the cingulate cortex is often parcellated into posterior and anterior
segments (Figure 1.2) with both contributing to autonomic regulation, specifically modulations
of heart rate and blood pressure12,16,17. The anterior cingulate cortex (ACC) is interconnected
with the anterior insula18, and therefore it is not surprising that the ACC is also commonly
activated during maneuvers that elicit an increase in sympathetic activity such as the Valsalva
maneuver, maximal inspiratory apneas and lower-body negative pressure19. Furthermore, like the
anterior insular cortex, increased ACC activation has been coupled with direct recordings of
sympathetic nerve activity14,15. In contrast, sub-motor somatosensory stimulation of small Type
III and IV muscle afferents, along with corresponding changes in parasympathetic indicators (i.e.
high frequency heart rate variability) have produced posterior cingulate activation20.

Figure 1.2. Anterior (ACC) and Posterior (PCC) Cingulate Cortices
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1.5.3

Cerebellum

Dating back to the 17th C, in an attempt to understand the ANS, Thomas Willis found that some
neural pathways appeared to take place without cerebral involvement. He postulated that the
cerebrum controlled voluntary movement, whereas the cerebellum (Figure 1.3) was the
originating point for involuntary movement. This theory regarding sympathetic control stemming
from the brainstem and cerebellum was later altered by Robert Whytt1. This three-century-old
idea would only be superficially discussed until nearly 80 years ago when Giuseppe Moruzzi
showed that electrical stimulation of the cerebellum could affect various autonomic reflexes,
including vasomotor, respiratory and carotid sinus reflexes21. Since then, research regarding
cerebellar influences on autonomic processes has grown considerably. Yet, in 2016 the
recommendations of a consensus panel still identified the contributions of the human cerebellum
to autonomic control as an area deserving more attention and further investigation22.
Anatomically, the cerebellum is connected to the brainstem via three cerebellar (inferior, middle
and superior) peduncles. Furthermore, tracing studies have revealed the structural network of
neurons projecting from the cerebellum to the NTS, RVLM, PBN and NA23–25. These anatomical
networks support a functional role for the cerebellum in cardiovascular autonomic regulation.
Functionally, the cerebellum integrates vestibular and somatosensory information regarding
movement and postural adjustment. More specifically, the cerebellum integrates positional
changes related to head-up tilt and upright posture. In response to postural changes to an upright
position, the cerebellum integrates vestibular information and facilitates an early increase in
efferent sympathetic outflow26. The integration of both vestibular and autonomic signals,
together, establishes the vestibulo-sympathetic reflex (VSR). Cerebellar involvement in the VSR
has been established in both animal and human models. For example, cerebellar stimulation in
animal models produces significant cardiovascular responses including increased cerebral blood
flow, tachycardia and arterial pressor responses with measurable increases in muscle, splanchnic
and renal sympathetic nerve activity26–31. In healthy individuals, neuroimaging studies have
demonstrated cerebellum and deep cerebellar nuclei activation during challenges involving
increased sympathetic activity such as the Valsalva maneuver, inspiratory capacity apnea and
lower-body negative pressure14,15,32. Furthermore, increase activity in the cerebellum/deep
cerebellar nuclei was demonstrated to occur with concomitant increases in muscle sympathetic
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nerve activity14. Finally, damage to the cerebellum has been shown to result in long-term
impairment of cardiovascular responses including orthostatic hypotension and autonomic
dysregulation33–35.

Figure 1.3. Cerebellum

1.6

Evaluation of autonomic function: clinically validated tests

Due to the widespread nature of the autonomic network and its complex integration within a
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number of organs and systems, the impact of autonomic dysfunction or failure can be extremely
disabling. Therefore, reliable and validated methods of evaluation are of utmost importance. The
Autonomic Reflex Screen (ARS) is a battery of non-invasive, standardized autonomic tests to
evaluate the presence, severity and distribution of autonomic dysfunction. The ARS is comprised
of four evaluations including: 1) Quantitative sudomotor axon reflex test (QSART), 2) heart rate
responses to deep breathing (HRDB), 3) heart rate and blood pressure responses to Valsalva
maneuver (VM) and 4) heart rate and blood pressure responses to head-up tilt (HUT)36,37.

1.6.1

Quantitative Sudomotor Axon Reflex Test (QSART)

Quantitative Sudomotor Axon Reflex Test (QSART) evaluates the integrity of postganglionic
sympathetic axons by means of transdermal iontophoresis of acetylcholine (ACh) for 5 minutes
with a constant current generator set to 2 mA. The neural pathway consists of an axon reflex
mediated by the postganglionic sympathetic sudomotor axon. The axon terminal is activated by
ACh, creating an antidromic impulse that travels to a branch point. Subsequently, an orthodromic
impulse travels to a secondary nerve terminal whereby ACh is released. ACh released from the
secondary axon terminal binds to muscarinic receptors on eccrine sweat glands to evoke a
reflexive sweat response. Following stimulation, an additional 5-minutes of recording provides a
measurable residual sweat response. QSART is performed at four standard sites, the forearm,
proximal leg, distal leg and foot, to provide a measure of axon integrity of the ulnar, peroneal,
saphenous and sural, respectively. Total sweat volumes are measured by a sudorometer and
calculated based on an integrated area under the curve of the entire 10-minutes. Reduced or
absent sweat responses can be indicative of impaired postganglionic sympathetic axon integrity
(Figure 1.4)36,37.
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Figure 1.4 Quantitative Sudomotor Axon Reflex Test (QSART).
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1.6.2

Heart Rate Response to Deep Breathing (HRDB)

Breathing naturally causes a pattern of discharge from the vagus nerve, and the rate of discharge
can be influenced by the rate and depth of respiration. The vagal innervation to the heart contains
both the afferent and efferent pathways for this reflex arc, and therefore the maneuver is regarded
as a measure of cardiovagal function. To produce the maximal variation between breaths,
individuals are asked to complete eight breathing cycles at a rate of 6 breaths/minute38. During
analysis, the five highest consecutive peak-to-trough heart rate differences are calculated and
averaged to provide an average heart rate response to deep breathing. A healthy cardiovagal
response will show HR fluctuations in response to the maneuver (Figure 1.5A), whereas reduced
heart rate responses are indicative of cardiovagal impairment (Figure 1.5B).
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Figure 1.5 Heart Rate Responses to Deep Breathing (HRDB).
Normal (A) and severely reduced (B) heart rate responses to deep breathing. (B) represents
cardiovagal impairment
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1.6.3

Valsalva Maneuver (VM)

Valsalva maneuver (VM) is a simple and non-invasive clinical test ideal for providing important
information regarding both sympathetic and cardiovagal functioning. The maneuver reflex is
mediated by the baroreflex and changes in intra-thoracic pressures. In practice, participants are
asked to exhale at an expiratory pressure of 40 mmHg held for 15 seconds. In doing so, a classic
quadri-phasic change in blood pressure is produced in healthy individuals to provide insight into
adrenergic function (Figure 1.6A).

Phase I: Phase I is mechanical in nature, upon inhalation there is a large increase in intra-thoracic
pressure that causes compression of the aorta and a subsequent small increase in systolic blood
pressure (SBP).
Phase II_Early: In early phase II there is a transient decline in SBP due to a reduced stroke
volume and consequently a reduction in cardiac output (Q).
Phase II_Late: Within approximately 4 seconds, the drop in SBP is arrested, and starts to
increase again. This occurs as a result of increased plasma concentration of norepinephrine (NE)
and increased sympathetic discharge, which together results in an increase in total peripheral
resistance (TPR).
Phase III: Phase III, similar to Phase I, is mechanically mediated. Upon release of the maneuver
there is a drop in intra-thoracic pressure that results in a rapid drop in SBP for about 1-2 seconds.
Phase IV: As a result of the sudden drop in SBP in Phase III, there is a burst in sympathetic
activity that increases Q. Increased Q in conjunction with the increased TPR from Phase II_Late,
results in a large SBP overshoot above baseline levels. In contrast, reduced or absent adrenergic
phases (late phase II and phase IV) provide evidence of adrenergic failure (Figure 1.6B).

An additional measure of cardiovagal functioning can be derived from the heart rate response to
the VM. The Valsalva ratio (VR) is calculated from the highest heart rate generated from the
maneuver divided by the lowest heart rate achieved following maneuver release. Physiologically,
this occurs as there is a progressive compensatory tachycardia due to the decrease in SBP
starting from Phase II_Early. Subsequently, the Phase IV SBP overshoot is accompanied by a
transient bradycardia following release of the maneuver.
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A

B

Figure 1.6. Heart rate and blood pressure responses to Valsalva maneuver
(A) Healthy individuals show reproducible quadri-phasic blood pressure responses to Valsalva
and large tachycardic response. (B) Patients with autonomic failure will have absent late phase
II and phase IV blood pressure responses, along with impaired heart rate responses.
Abbreviations: HR, Heart rate; bpm, beats per minute; SBP, systolic blood pressure; mmHg,
millimeters of mercury; II_E, Phase II_Early; II_L, Phase II_Late
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1.6.4

Head-up Tilt (HUT):

In response to an orthostatic challenge such as a passive head-up tilt (HUT), there are natural
mechanisms to counteract the effects of gravity to maintain adequate blood pressure at the head
and heart level. HUT is commonly the last test of the ARS as individuals should remain supine
for a minimum of 20 minutes prior to tilt to allow for equal redistribution of intravascular
volume, stable basal sympathetic nerve output and to maximize the degree of orthostatic stress.
Following baseline, individuals are slowly (~10 seconds) and passively tilted to 70° from the
horizontal. (Note: The 70° angle was found to produce a maximal orthostatic stress while
minimizing the effects of muscular contraction.) Within the first 30 seconds of HUT it is
common for healthy individuals to experience a transient and modest (<10 mmHg, mean BP)
decline in systolic, diastolic and mean blood pressures followed by recovery within the first
minute (Figure 1.7A). This recovery is mediated by sympathetic activation resulting in reflexive
tachycardia, increased release of norepinephrine and increased TPR via vasoconstriction.
Therefore, measuring the changes in HR and SBP in response to HUT provides a measure of
sympathetic function. The duration of HUT is variable depending on the clinical investigation.
For example, the clinical criterion for diagnosing postural orthostatic tachycardia syndrome is
minimum tilt duration of 10 minutes. In contrast, individuals with evidence of neurogenic
orthostatic hypotension (Figure 1.7B) may only last 1-2 minutes before tilt needs to be aborted
due rapid and severe orthostatic hypotension.
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A

B

Figure 1.7 Hemodynamic response to Head-up Tilt (HUT).
(A) Healthy individuals show transient decline in systolic blood pressure at onset of head-up
tilt (HUT). This is accompanied by an appropriate compensatory postural tachycardia (black
line) and subsequent BP recovery. (B) Clear evidence of Neurogenic Orthostatic Hypotension
with no compensatory postural tachycardia.
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1.6.5

Composite Autonomic Severity Score

The composite autonomic severity score (CASS) is derived from the autonomic reflex screen and
is normalized for age and sex39. The CASS is a validated score used to quantify autonomic
dysfunction and provide a measure of the severity and distribution of autonomic failure40. The
11-point CASS (0-10) is divided into three indices: Sudomotor Index (0–3), Cardiovagal Index
(0–3), and Adrenergic Index (0–4). Patients with a composite score ranging from 1-3 are
considered to have mild autonomic dysfunction, 4-6 are considered moderate, and 7-10 have
severe autonomic failure. A score of 0 would indicate no autonomic dysfunction.

1.7

Patient Self-report Instruments

In addition, there are a number of self-report questionnaires that have been validated for clinical
autonomic populations. Two common questionnaires include the Autonomic Symptom Profile
and the Orthostatic Hypotension Questionnaire.

1.7.1

Autonomic Symptom Profile

The autonomic symptom profile (ASP) is a validated self-report instrument designed to provide
an index of autonomic symptom severity41. The ASP is comprised of 169 questions to yield a
Composite Autonomic Symptom Scale (COMPASS) reflecting overall severity of autonomic
symptoms. There are 10 subscale scores (11 for men) that assess severity of symptoms within the
following domains: orthostatic intolerance, bladder dysfunction, diarrhea, gastroparesis,
secretomotor dysfunction, syncope, sleep disorder, constipation, vasomotor symptoms, and
pupillomotor symptoms and sexual dysfunction for men. The highest possible overall score for
men is 200 and 170 for women, with higher scores indicating more autonomic symptomatology.
Newer and briefer versions of the COMPASS (COMPASS 31) are currently available42.

1.7.2

Orthostatic Hypotension Questionnaire

The Orthostatic Hypotension Questionnaires (OHQ) is a 10 question self-report questionnaire to
assess symptoms related to a low blood pressure problem. The OHQ yields the following two
sub-scores: Part I: the orthostatic hypotension symptoms assessment (OHSA), and Part II: the
orthostatic hypotension daily activity scale (OHDAS). The OHSA consists of six questions to
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measure the presence and severity of orthostatic symptoms, while the OHDAS consists of four
questions to assess the impact of orthostatic symptoms on daily activities43. Each item is scored
on an 11-point scale from 0–10, with 0 indicating no symptoms/no interference and 10 indicating
the worst symptoms/complete interference. Included in the questionnaire is an additional option
of “cannot do for other reasons”.

1.8
1.8.1

Evaluation of autonomic function: additional tests
Lower Body Negative Pressure (LBNP):

Lower body negative pressure (LBNP) investigates the effects of blood volume displacement to
reliably activate the baroreflex through baroreceptor unloading. In the supine position,
individuals are sealed from the waist down in an airtight container connected to a vacuum.
Negative pressure applied to the lower half of the body redistributes blood from the upper to the
lower extremities resulting in relative central hypovolemia. The level of suction (i.e. negative
pressure) can be precisely monitored using a manometer and rapidly controlled through valves
that open to room pressure. When applied at lower levels (< 15 mmHg), LBNP reduces central
blood volume and increases peripheral sympathetic activity primarily by unloading
cardiopulmonary baroreceptors. At higher levels of suction (>30 mmHg), there is additional
arterial baroreceptor unloading, to cause further reductions in CBV, accompanied by reduced
cardiac filling and stroke volume. As a result, these changes produce reflex tachycardia and even
greater levels of peripheral sympathetic activity44–46. LBNP provides a technique, especially for
patients with limited mobility and functional imaging studies, as the testing can be executed
entirely in the supine position. Clinically, LBNP provides an orthostatic stress equivalent to that
of head-up tilt (Figure 1.8).
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Figure 1.8 Lower Body Negative Pressure (LBNP) in patient with autonomic failure.

Abbreviations: HR, Heart rate; bpm, beats per minute; SBP, systolic blood pressure; mmHg,
millimeters of mercury; LBNP, lower body negative pressure.
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1.8.2

Functional Magnetic Resonance Imaging (fMRI)

Functional magnetic resonance imaging (fMRI) provides a non-invasive modality for mapping
patterns of brain activation and therefore has emerged as a leading tool in both clinical and
research settings. In brief, the blood-oxygen-level-dependent (BOLD) response, generally
measured by means of a T2*-weighted sequence, takes advantage of the tight coupling between
neural activity, cerebral blood flow and the change in magnetic properties as hemoglobin shifts
from oxygenated (Hb) to deoxygenated (dHb). The MR signal intensity is distorted by the
magnetic properties of dHb. Therefore, a relative change in dHb produces a change in MR
signal. The BOLD response to a short stimulus shows the following three phases: 1) Fast
response/early dip, 2) Main BOLD response and, 3) Post-stimulus undershoot (Figure 1.9).

Figure 1.9 Blood Oxygen Level Dependent (BOLD) response to a stimulus

Adapted from Norris D. (2006) Principles of magnetic resonance assessment of brain
function. Journal of Magnetic Resonance Imaging. 23(6): 794-807.

The BOLD contrast is influenced by three physiological parameters: the rate of oxygen
consumption, regional cerebral blood flow (rCBF) and regional cerebral blood volume (rCBV).
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The initial negative dip in signal intensity following a stimulus is due to increased oxygen
consumption (i.e. increase in dHb) without any appreciable changes to rCBF and rCBV. The
main BOLD response reflects an increase in rCBF and rCBV causing a reduction in the amount
of dHb, and subsequent large MR signal. Finally, post-stimulus undershoot is thought to be due
to a maintained rate of oxygen consumption once blood flow has returned to baseline. Overall,
the BOLD response provides an indirect measure of brain activity, as an increase in neural
activity will increase all three parameters facilitating a measurable BOLD response47–49.
Since the emergence of functional imaging, brain mapping has focused largely on localizing
brain functions. However, in the last decade the neurosciences has seen a shift from functional
segregation to functional integration. fMRI data has been analyzed to greater depths to reveal
how neural systems may be coupled to perform specific functions. The organization and
integration of different brain regions is commonly referred to as “functional connectivity”: an
attempt to look at the functional architecture of the brain. Functional connectivity attempts to
quantify the interactions of distinct brain regions that are simultaneously engaged during a
specific task using correlations or covariances of activity derived from the BOLD data.

1.9

Autonomic Failure

Orthostatic hypotension (OH) is present in 5-30% of persons ≥65 years50,51. Neurogenic OH
(NOH) can be differentiated from other causes of OH, such as hypotension due to endocrine
issues, generalized low blood pressure, low blood volume, etc., in that NOH is associated with
impairment of the sympathetic nervous system52–54. NOH is clinically defined as a sustained
reduction in systolic blood pressure (SBP) ≥20 mmHg or diastolic blood pressure of ≥10 mmHg
within 3 minutes of standing or head-up tilt without an appropriate compensatory tachycardia55
(Figure 1.7B). To improve the false positive detection rate from 5% to 1%, and in patients with
autonomic failure plus supine hypertension, a SBP reduction ≥30 mmHg or a diastolic drop ≥15
mmHg is recommended54,56. NOH is a cardinal feature of autonomic failure. The term
“autonomic failure” represents a broad description of generalized pan-dysautonomia that can
occur independently or accompany a number of disorders. Generally, clinical classifications of
NOH secondary to autonomic failure can be made based on where failure of the sympathetic
efferent signaling pathway occurs i.e. before or after the autonomic ganglia. For example, NOH
occurs in disorders of the central nervous system /pre-ganglionic lesions including: Multiple
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System Atrophy (MSA) and Lewy Body Dementia (LBD). In contrast, clinical populations such
as Parkinson’s Disease (PD) with autonomic failure, Pure Autonomic Failure (PAF), Diabetic
Autonomic Neuropathies, etc., the lesion site is considered to be “post-ganglionic”/peripheral.

1.9.1

Pre-ganglionic Disorders

Multiple System Atrophy: Multiple system atrophy (MSA) is a sporadic neurodegenerative
disorder involving progressive deterioration of three specific regions of the brain and
preganglionic nerves. Degeneration of the basal ganglia, cerebellum and pons give MSA a
clinical triad of symptomatology resembling Parkinson’s Disease, cerebellar ataxia and
autonomic failure. MSA is considered pre-ganglionic and as such patients will typically have
intact post-ganglionic sympathetic nerves. However, as the disease progresses some patients can
acquire post-ganglionic denervation resulting in more widespread autonomic failure affecting
blood pressure regulation, bowel and bladder dysfunction, respiration, sleep, etc. The prognosis
of MSA is poor relative to other forms of autonomic dysfunction, with life expectancy ranging
from 7-10 years following symptoms onset57. Particularly, following the development of severe
autonomic failure, including NOH, survival is reduced by 2.3 years58.

Lewy Body Dementia: Lewy Body Disorders (LBD) are identified by an accumulation of a
protein called alpha-synuclein, also known as Lewy bodies, around the neuronal cell body and
synaptic terminals53. Clinical features vary depending on the location of accumulation; however,
autonomic failure and NOH are prominent in most Lewy body disorders. Unlike MSA, dementia,
cognitive impairment and visual hallucinations are more prominent in LBD due to Lewy body
accumulation in the basal forebrain and cerebral cortex.

1.9.2

Post-ganglionic Disorders

Pure Autonomic Failure: Pure Autonomic Failure (PAF) is a sporadic and chronic peripheral
degenerative disorder characterized by autonomic failure without any other neurological deficits,
including central degeneration, motor and sensory deficits. A clinical diagnosis of PAF is based
on widespread and persistent sympathetic and parasympathetic dysfunction without any evidence
of other pathology for an extended period of time. Despite significantly autonomic dysfunction,
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PAF patients typically have normal life expectancies. Autonomic issues include: neurogenic
orthostatic hypotension, erectile dysfunction, impaired sweating, bowel and bladder dysfunction
and dry mouth.
Parkinson’s Disease plus Autonomic Failure: NOH and autonomic dysfunction is present in
approximately 30% of patients with Parkinson’s disease (PD)59. Despite neuronal death within
the substantia nigra, which accounts for many Parkinsonian symptoms, clinical literature
provides robust evidence that supports PD plus Autonomic failure as a post-ganglionic disorder.
Studies involving various testing of post-ganglionic sympathetic nerve integrity, including
neuroimaging, pharmacological and neurochemical, have repeated revealed post-ganglionic
sympathetic denervation in PD plus autonomic failure patients52,60–62. The most common
autonomic problems include, neurogenic orthostatic hypotension, bowel and bladder
dysfunction, gastrointestinal dysmotility and sexual dysfunction63.

Idiopathic NOH: Approximately 1/3 of patients with NOH have no identifiable underlying cause
for dysfunction64 and as such NOH can occur as an independent entity, or the course of their
disease has not become clear. Patients diagnosed with idiopathic NOH typically have
considerable orthostatic hypotension, along with gastrointestinal issues or other questionable
phenomenon such as olfactory impairment, but do not meeting criteria for other alphasynucleinopathies. Patients with idiopathic NOH may develop a clearer diagnose over time.

1.10

Neurogenic Orthostatic Hypotension

Neurogenic Orthostatic Hypotension (NOH) is a disorder affecting individuals globally, but
arguably has received considerably less attention than its counterpart, hypertension. Presently,
there are several gaps in our overall understanding and assessment of patients with NOH related
to autonomic failure.

First, regardless of the underlying etiology (i.e. pre- versus post-ganglionic), impairment of
higher cortical and subcortical regions has not been investigated in the pathophysiology of NOH.
Specific areas of the brain such as the cingulate cortex, insula, hippocampus and cerebellum,
which have all been highlighted as key cortical structures in autonomic regulation. Importantly,
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these structures have been shown to contribute to the proper regulation of basic autonomic
functions such as heart rate and blood pressure; the same key autonomic functions that fail in
patients with NOH12,20,32,65,66.

Second, NOH is a debilitating condition associated with reduced quality of life, impaired
function and is an independent predictor of mortality67–69. Common symptoms include: fatigue,
weakness, head and neck pain, dizziness, lightheadedness, pre-syncope, and in some cases, full
syncope55. Unfortunately, these symptoms are typically regarded as ‘constitutional’ or nonspecific, that is, symptoms that can be related to many different systems and the results of a
plethora of underlying causes. For this reason, a proper diagnosis of NOH can be challenging,
especially for clinicians without significant experience in disorders of the ANS. Furthermore,
roughly 50% of patients with NOH also have supine hypertension, which can distract
practitioners who may then fail to obtain upright blood pressure measurements. Accurate
identification of autonomic dysfunction lies in the ability to appropriately discern these
symptoms on the basis of position. Autonomic symptomatology is posturally-related; patients
can be extremely symptomatic in the upright position, but these can often be completely relieved
by resuming a seated or lying position. Therefore, clinicians must identify these symptoms as
being either orthostatic or non-orthostatic to help guide them towards a proper diagnosis of
NOH. Unfortunately, clinicians do not have available to them a simple, non-invasive tool that
they can administer to help make this distinction. Therefore, under these circumstances, more
common syndromes and disorders associated with light-headedness, dizziness, etc., such as inner
ear or vestibular issues, vertigo, migraines, hypoglycemia, anemia and even certain medication
side effects, may be considered as differential diagnoses prior to orthostatic intolerance that
accompanies NOH.
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1.11

Purposes and Hypotheses

Therefore, the primary purpose of the studies described herein (Chapters 2-7) was to improve our
assessment and understanding of Neurogenic Orthostatic Hypotension. More specific objectives
and hypotheses are as follows:
Study 1 Objective: Evaluate brain activation patterns in NOH patients using functional
MRI during standard tests of autonomic functioning.
Hypothesis: Relative to healthy controls, patients with NOH will demonstrate reduced
activity in central autonomic structures during autonomic maneuvers.
Study 2 Objective: Evaluate functional connectivity between the brainstem and central
autonomic structures at rest and during autonomic challenges in NOH patients.
Hypothesis: NOH patients will demonstrate reduced brainstem connectivity relative to
their healthy counterparts
Study 3 Objective: Based on the results of study 1, we aimed to investigate cerebellar
functional connectivity in NOH patients at rest and during autonomic maneuvers.
Hypothesis: Patients with NOH will demonstrate reduced cerebellar connectivity to key
central autonomic structures.
Study 4 Objective: Create a self-report questionnaire to identify and assess patients with
autonomic dysfunction based on symptomatology; evaluate validity and reliability.
Hypothesis: The questionnaire will demonstrate preliminary validity and reliability
within a sample population of patients with orthostatic intolerance associated with autonomic
dysfunction.
Study 5 Objective: Assess sensitivity and specificity of the questionnaire, inter-item
reliability and the ability to positively predict patients with orthostatic dysfunction secondary to
autonomic dysfunction.
Hypothesis: The questionnaire will produce symptom scores that are sensitive and
specific and will be capable of positively identifying patients with orthostatic symptoms related
to autonomic dysfunction.
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CHAPTER 2

2

Impaired cortical autonomic responses during sympathetic activation in Neurogenic
Orthostatic Hypotension characterized by post-ganglionic autonomic dysfunction1

2.1

Introduction

Neurogenic orthostatic hypotension (NOH) is a debilitating condition associated with
reduced quality of life, impaired function and is also an independent predictor of mortality1–3.
NOH is clinically defined as a sustained reduction in systolic blood pressure (SBP) ≥20 mmHg
or diastolic blood pressure of ≥10 mmHg within 3 minutes of standing or head-up tilt performed
at 60° without an appropriate compensatory postural tachycardia4. However, to improve the false
positive detection rate from 5% to 1%, in patients with autonomic failure, a SBP reduction ≥30
mmHg or a diastolic drop ≥15 mmHg is recommended5,6. Specifically, neurogenic OH can be
differentiated from other causes of orthostatic hypotension, such as hypotension due to endocrine
issues, generalized low blood pressure and low blood volume, in that a lesion is present in a
specific region of the nervous system, known as the autonomic nervous system. Specifically,
dysfunction of reflexive responses mediated by the sympathetic nervous system7,8. Autonomic
dysfunction can be further defined as either central or peripheral. For example, in Multiple
System Atrophy, atrophy of the pons results in significant autonomic failure9. In contrast,
peripheral autonomic disorders such as, pure autonomic failure, Parkinson’s Disease with
autonomic failure and idiopathic NOH are characterized by lesions in the post-ganglionic
sympathetic fibres8. Regardless of the underlying etiology, both central and peripheral autonomic
lesions result in a significant drop in blood pressure as patients move from sitting to standing,
which can lead to inadequate cerebral blood flow and reduced cerebral perfusion pressure in
various cortical regions10. As cerebral blood flow and perfusion pressure are crucial factors in
normal brain function, failure to adequately control these variables may significantly impact the
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functionality of cortical networks. Recent advances in neuroimaging, specifically, functional
magnetic resonance imaging (fMRI), has facilitated research mapping brain activation patterns
by exploiting the relationship between neural activity, energy metabolism and cerebral blood
flow. As a result, specific areas of the brain such as the cingulate cortex, insula, hippocampus
and other cortical regions have been implicated in autonomic regulation. Furthermore, these
structures have extensive cortical-cortical and cortical-subcortical projections to structures that
regulate autonomic responses11, and in animal and human studies alike, have been shown to
influence autonomic parameters including heart rate and blood pressure12–16. Finally, in a clinical
context, damage to these areas due to stroke or lesion has been shown to disrupt regular
autonomic functioning17–19. Together these areas make up part of the central autonomic
network11,13,14.
Given the clinical context of autonomic failure, and the prominent feature of NOH leading to
alterations in cerebral blood flow and perfusion pressure, the objective of this study was to
evaluate brain activation patterns of NOH patients in response to standard tests of autonomic
function. Patient blood oxygen-level dependent activation patterns were compared against
healthy age-matched participants to investigate whether impairment of central autonomic
structures is involved in the pathophysiology of NOH.

2.2
2.2.1

Methods
Study participants

The current study included 15 healthy, age-matched controls (63±13 years) and 15 patients
diagnosed with Neurogenic Orthostatic Hypotension (NOH) (67±6 years) (p=0.12) related to a
peripheral autonomic lesion. Patients were recruited from the Autonomic Disorders Laboratory
in the Department of Clinical Neurological Sciences, London Health Sciences Centre, London,
Ontario, Canada. Patients with evidence of central autonomic dysfunction were excluding to
remove potentially confounding variables that would directly affect specific regions within the
Central Autonomic Network (CAN). Prior to testing, all diagnoses were clinically confirmed by
a Neurologist with specialty training in autonomic dysfunction (KK). Patients were clinically
evaluated as having peripheral forms of autonomic failure based on neurological examination,
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patient history (i.e. no evidence of REM sleep behaviour disorder, olfactory dysfunction, etc.)
and diagnostic work-up (i.e. blood work, brain MRIs, and responsiveness to treatment). The
NOH patient cohort was comprised of patients with evidence of peripheral autonomic
denervation (pure autonomic failure, n=3; Parkinson’s Disease + NOH, n=7; idiopathic NOH,
n=5). Patients were excluded if there was evidence of any peripheral nerve injury unrelated to
their diagnosis of autonomic dysfunction including diabetic neuropathies in any form. The
patient cohort reported an average symptom duration of 7±5 years. Healthy participants were
also examined to confirm the absence of any neurological conditions including autonomic
dysfunction. Healthy participants were recruited from the general population, including
recruitment from aging activity centers in London, Ontario. In addition, healthy participants were
excluded if they fell under any one of the following categories: i) clinically significant coronary
artery disease, ii) concomitant therapy with anticholinergic, alpha- and beta-adrenergic
antagonists or other medications which could interfere with autonomic functioning, and iii)
failure of other organ systems or systemic illness that could affect autonomic function or
participants’ ability to cooperate. All laboratory data were collected in the Autonomic Disorders
Laboratory at University Hospital, London, Ontario. All functional imaging data were collected
at Robart’s Research Institute Centre for Functional and Metabolic Imaging at The University of
Western Ontario. Ethical approval was obtained from the Health Science Research Ethics Board
at Western University, and informed consent was obtained from all participants prior to any and
all testing.

2.2.2

Autonomic testing

All participants underwent a battery of standardized and validated tests of autonomic function,
namely the autonomic reflex screen (ARS)20,21. In brief, quantitative sudomotor axon reflex test
(QSART) provided an assessment of post-ganglionic sympathetic function from four standard
sites (forearm, proximal leg, distal leg and foot). Adrenergic function was assessed by the beatto-beat blood pressure (BP) and heart rate (HR) responses to head-up tilt (HUT) performed at
70° from the horizontal for a maximum of 5 minutes and the Valsalva maneuver (VM)
performed at an expiratory pressure of 40 mmHg for 15 seconds. Cardiovagal function was
evaluated by the Valsalva ratio, and the HR responses to deep breathing. The composite
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autonomic scoring scale (CASS) was derived as a quantitative measure of the ARS22. In the lab,
beat-to-beat BP and HR responses were measured using a BMEYE Nexfin device (Amsterdam,
The Netherlands) and an electrocardiography (ECG) device (Model 3000 Cardiac Trigger
Monitor, IVY Biomedical Systems, Inc., Branford, CT) with ECG electrodes (Ambu® Blue
Sensor SP, Glen Burnie, MD), respectively. All recordings were made using WR TestWorksTM
software (WR Medical Electronics Co., Stillwater, MN). Participants repeated deep breathing
and Valsalva during a functional MRI with the same aforementioned parameters. However, as
opposed to only performing two trials of each task, participants were instructed to perform four
deep breathing exercises and three VMs.

2.2.3

Neuroimaging data acquisition

All imaging data were collected using a whole body 3T imaging system (Magnetom Primsa,
Siemens Medical Solutions, Erlangen, Germany) with a 32-channel head coil. A high-resolution
T1-weighted structural volume was acquired with a 3D MPRAGE sequence at the beginning of
the scanning session (sagittal, matrix 256x240 mm, voxel resolution 1.0x1.0x1.0 mm, 1 mm slice
thickness, no gap, flip angle 9 degree, TE: 2.98 ms, TI: 900 ms, TR: 2300 ms). Blood oxygen
level-dependent (BOLD) signals were acquired to provide an indirect measure of brain
activation. Due to the paramagnetic properties of deoxygenated haemoglobin (dHb), there is
distortion of the acquired magnetic signal that is related to changes in the amount of dHb present
in the tissue. Therefore, changes in the magnetic signal as a result of changes in the amount of
oxygenated Hb versus dHb provide an indirect measure of tissue oxygen extraction and thus
activation23. BOLD signals were acquired using a T2- weighted gradient echo-echo planar
imaging pulse sequence with the following parameters: TE: 3 0ms; FOV: 240x240 mm; flip
angle: 40 degrees; multiband acceleration factor: 4. Forty-eight interleaved axial slices (3.0x3.0
mm in-plane voxel resolution, TR: 1000 ms) were acquired in each volume.

2.2.4

MRI experimental paradigm

Participants completed 4 deep breathing exercises (120 seconds each) with 60 seconds of rest in
between each trial (620 volumes) and 3 VMs (15 seconds each) with a 60-second baseline and
120 seconds of rest in between each trial (465 volumes). The first 2 volumes of each test were
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discarded from analysis to allow for an equilibrated MRI signal. To minimize head movement,
each participant’s head was placed in a cradle packed with foam padding. In addition, all
participants practiced the protocol prior to scanning to help minimize head movements during
each experimental protocol and were instructed to avoid head movements as much as possible.
Beat-to-beat heart rate was recorded from the continuous signal derived from an MRI-compatible
pulse oximeter (Nonin Medical, 8600FO MRI, Plymouth, MN) attached to the index finger of
each participant’s left hand when possible. In the presence of a significant tremor i.e. in
PD+NOH patients, pulse oximetry was obtained from the hand with less potential for movement.
All hemodynamic recordings were collected using WR TestWorks™ software (WR Medical
Electronics Co., Stillwater, MN).

2.2.5

Neuroimaging data analysis

Raw fMRI data were analyzed using SPM12 (Wellcome Department of Imaging Neuroscience,
London, UK). All functional images were realigned using a rigid body transformation to correct
for head motion using the mean functional image. All images were co-registered with the T1weighted scan, normalized to standard stereotaxic space (Montreal Neurological Institute; MNI)
and smoothed with a 6mm FWHM Gaussian kernel. To reduce low frequency noise, a high pass
filter with 128s cut-off was applied.

Two levels of analysis were performed. First, individual design matrices were constructed for
each experimental protocol (HRDB and VM) modeled by a box-car and convolved with a
canonical hemodynamic response function. The General Linear Model was used to create a
statistical parametric map on a voxel-by-voxel basis24. Second, the average contrast image from
each individual, for each experiment protocol [VM and HRDB] was entered into a 2-sample
independent t-test. Significant changes in signal intensity from rest were determined for each
paradigm (DB and VM). An additional contrast of phase IV of VM (10 seconds following
release of the maneuver) was compared against rest. In contrast to the entire VM that
incorporates both parasympathetic and sympathetic components of the ANS, 10-seconds
following the immediate release of the maneuver was chosen to capture a phase that is primarily
adrenergically-mediated25. Signal intensity differences between controls and patients were
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compared using subtraction analysis. These contrasts included: Control VM>Patient VM [1, -1],
Patient VM>Control VM [1, -1], Control VM Phase IV>Patient VM Phase IV [1, -1], Patient
VM Phase IV> Control VM Phase IV [1, -1], Control HRDB>Patient HRDB [1, -1] and Patient
HRDB>Control HRBD [1, -1]. Comparisons of the BOLD responses were corrected for multiple
comparisons (family-wise error (FWE) <0.05) with a cluster threshold of 10 voxels. In some
cases, a more lenient threshold of p<0.001, uncorrected was used.

2.2.6

Regions-of-Interest analysis

Regions of interest (ROI) were determined based on previous work highlighting regions of the
central autonomic network. These a priori ROI included the bilateral insula, bilateral anterior and
posterior cingulate, bilateral hippocampus and bilateral thalamus. All ROI masks were created
using WFU_Pick Atlas toolbox version 1.226,27.

2.2.7

Statistical analysis

Physiological data are presented as mean ± standard deviation. Autonomic parameters between
NOH patients and age-matched controls were compared using an independent t-test. All tests
were 2-tailed with a p-value <0.05 to denote significance. All statistical analyses were performed
using SPSS statistical software, Version 22.0. Manufactured by International Business
Management (IBM) Corporation (SPSS Inc. Chicago, IL).

2.3
2.3.1

Results
Hemodynamic responses

Quantitative Sudomotor Axon Reflex Test: There was evidence of significantly smaller sweat
volumes at the proximal and distal leg, and a trend toward smaller sweat volumes at the forearm
(p=0.07) in patient with NOH. The foot showed no significant sweat volume differences between
patients and controls. Even though the sweat response at the foot was not significantly different
from the control group, these values were still considered reduced relative to normative data,
suggesting impairment in the sweat response at this site8 (Table 2.1). Overall, these data are still
in keeping with autonomic dysfunction related to peripheral (post-ganglionic) autonomic
impairment. Cardiovagal Index: Compared to controls, patients had significantly smaller heart
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rate (HR) responses to deep breathing and Valsalva ratios (p<0.001). This was evident in both
the lab and MRI protocols. Adrenergic Index: Patients had significantly larger SBP drops during
HUT with significantly smaller compensatory tachycardias (p<0.001) (Table 2.1). Qualitative
analysis of the VM demonstrated that patients with NOH had absent adrenergic phases in
response to the maneuver, resulting in a significantly larger Adrenergic Index as evaluated by the
CASS (Table 2.1). The Cardiovagal Index of the CASS showed a similar significant difference
between controls and patients (Table 2.1). Hemodynamic changes to autonomic maneuvers
showed no significant differences between the lab and MRI testing. The hemodynamic responses
to standard autonomic testing clearly support pan-dysautonomia with NOH, related to a
peripheral autonomic lesion.

2.3.2

Functional imaging

Cardiovagal Index: Healthy individuals demonstrated significant reductions in brain activity
relative to rest in the bilateral thalamus, bilateral insula, left posterior cingulate cortex (PCC),
and right parahippocampus (Table 2.2; Figure 2.1). Similarly, patients with NOH had significant
reductions in cortical activity relative to rest in the (PCC), right anterior CC and bilateral insula
(Table 2.2; Figure 2.1). Figure 5.2 provides a 3D render to better visualize insular deactivation in
both controls and patients during the parasympathetically mediated maneuver, deep breathing
(Figure 2.2). Furthermore, there was evidence of deactivation within the bilateral thalamus;
however, these regions did not reach significance. A subtraction analysis [controls>patients; 1, 1] [patients>controls, 1, -1] revealed no significant differences between controls and patients in
response to deep breathing.
Adrenergic Index: In contrast to cardiovagal function, the Valsalva maneuver revealed
significant differences between healthy controls and patients. A subtraction analysis
[controls>patients, 1, -1] revealed that controls had significantly greater activation during VM,
relative to rest, in the bilateral thalamus, left PCC, right ACC and right hippocampus.
Furthermore, during phase IV of the VM, the right hippocampus remained significantly more
activated in healthy controls relative to rest compared to NOH patients (Table 2.3; Figure 2.3).
Patients showed no significant activation during VM or Phase IV when the analysis was reversed
[patients>controls, 1, -1].
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Table 2.1. Anthropometric data and autonomic testing results
Anthropometric
Control (n=15)
Patient (n=15)
Mean ± SD
Mean ± SD
Age (years)
61±14
67±6
Range (years)
48-79
59-77
Sex M: F
7:8
9:6
BMI
26.3±3.4
25.5±5.1

p-value
=0.2

=0.6

Autonomic Testing:
QSART
Forearm
Proximal Leg
Distal Leg
Foot

1.31±0.72
1.23±0.93
1.23±0.86
0.91±0.68

0.81±0.69
0.47±0.47
0.44±0.40
0.65±0.50

0.07
0.009
0.004
0.24

Lab Deep Breathing (bpm)
MRI Deep Breathing (bpm)

15.2±8.3
15.3±9.6

3.7±2.0
5.7±2.1

<0.001
=0.002

Lab Valsalva Maneuver
MRI Valsalva Maneuver

1.9±0.4
2.1±0.47

1.21±0.17
1.22±0.11

<0.001
<0.001

Head-up Tilt
Resting Heart Rate (bpm)
62±9.7
70.5±11.3
0.03
∆Heart Rate
19.4±8.6
8.9±6.7
0.002
Resting SBP (mmHg)
117.1±14.9
146.3±25.2
0.001
∆SBP (mmHg)
-18.1±5.9
-79.7±25
<0.001
∆HR/∆SBP ratio during
1.1±0.5
0.15±0.2
<0.001
HUT
CASS
Sudomotor Index
0.2±0.7
0.87±1.1
=0.06
Cardiovagal Index
0.1±0.4
1.7±1.0
<0.001
Adrenergic Index
0.0±0.0
4.0±0.0
<0.001
Total
0.3±1.0
6.5±1.8
<0.001
Abbreviations: BMI; body mass index; QSART, quantitative sudomotor axon reflex test;
SBP, systolic blood pressure; ∆, change; MRI, magnetic resonance imaging; HR, heart rate;
∆HR, heart rate change; SD, standard deviation; CASS, Composite autonomic scoring scale
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Table 2.2. Brain regions of deactivation in response to deep breathing in healthy controls and
patients with NOH
Control Group
Deep breathing Deactivation
Region
Side
Coordinates
Voxel # T-score p-value
x
y
z
Thalamus
L
-18
-22
8
165
8.34
p<0.05
Thalamus
R
15
-19
8
149
7.19
p<0.05
PCC
L
-3
-37
38
681
7.31
p<0.05
Parahippocampus
R
30
-25
-19
59
6.72
p<0.05
Insula
L
-30
23
-4
218
6.39
p<0.05
Insula
R
39
-19
2
195
6.29
p<0.05
Patient Group
PCC
0
-37
35
365
8.5
p<0.05
ACC
R
6
35
26
173
6.89
p<0.05
Insula
L
-42
-16
2
50
6.91
p=0.007*
Insula
R
39
-19
5
55
6.81
p<0.05
*p-values uncorrected. Abbreviations: NOH, Neurogenic Orthostatic Hypotension; PCC,
posterior cingulate cortex; ACC anterior cingulate cortex; L, left; R, right.

Table 2.3 Brain regions of activation in response to Valsalva maneuver [controls-patients].
Valsalva Activation Control - Patient
Region
Side
Coordinates
Voxel # T-score p-value
x
y
z
ACC
R
15
50
14
57
4.29
p<0.009*
Hippocampus
R
42
-16
-16
11
8.03
p<0.05
PCC
L
-6
-46
26
19
7.6
p<0.05
Thalamus
L
-15
-10
11
46
8.45
p<0.05
Thalamus
R
15
-10
11
45
7.41
p<0.05
Valsalva Phase IV Activation Control - Patient
Hippocampus
R
24
-19
-16
48
5.78
p<0.05
*p-values uncorrected. Abbreviations: ACC, anterior cingulate cortex; PCC, posterior
cingulate cortex; R, right; L, left
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Figure 2.1 Cortical deactivation during deep breathing.
Cortical deactivation patterns relative to rest in healthy controls (n=15) and patients with NOH
(n=15) during Deep breathing. Abbreviation: PCC, posterior cingulate cortex; BOLD, bloodoxygen-level-dependent.
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Figure 2.2 3D visualization of insular deactivation
Insular deactivation in healthy controls (n=15) and NOH patients (n=15) during deep
breathing.
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Figure 2.3 Cortical and subcortical activation during Valsalva maneuver
Controls had significantly more brain activation relative to rest during the Valsalva maneuver and
during Phase IV following subtraction analysis [controls-patients]. Abbreviations: PCC, posterior
cingulate cortex; BOLD, blood oxygen level dependent.
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2.4

Discussion

Neurogenic orthostatic hypotension (NOH) is a cardinal feature of autonomic failure that results
from dysfunction of the reflexive regulation mediated by the sympathetic nervous system. As a
result, patients experience a considerable blood pressure reduction in the upright position.
Furthermore, an abundance of literature has highlighted specific autonomic brain regions in what
is commonly referred to as the central autonomic network (CAN). Our results reveal that patients
with NOH demonstrate similar cortical activation patterns in response to deep breathing - a test
of cardiovagal functioning. However, in response to Valsalva - an adrenergic indicator in its later
phase – patients with NOH are more profoundly affected with considerably less cortical
activation relative to healthy controls. These data further support dysfunction of the sympathetic
nervous system in the pathophysiology of NOH. However, they also add to the current
understanding by revealing additional impairment of the central autonomic network. The
relationship between NOH and changes in cortical autonomic regions during an adrenergic
maneuver such as the Valsalva may be due to impairment of cortical autonomic regions involved
in sympathetic/ baroreflex mediated pathways and reduced autonomic afferent signaling.

2.4.1

Impaired sympathetic/baroreflex mediated pathways

In autonomic failure, regardless of central or peripheral autonomic lesions, both clinical
populations demonstrate loss of baroreflex restraint/baroreflex buffering. In a study of primary
autonomic dysfunction, patients demonstrated significant baroreflex-adrenergic dysfunction
relative to healthy controls28. Our results go on to further suggest that cortical autonomic regions
associated with sympathetic and baroreflex activation may also be significantly affected in NOH
patients. Our results reveal that healthy controls have significantly more activation in the
thalamus, cingulate (bilateral PCC and right ACC) and hippocampus in response to VM relative
to patients. Functional imaging research has highlighted similar cortical and subcortical regions
to be involved in sympathetic and baroreflex mediated responses. For example, increased
activation of the hippocampus29 and thalamus16 have been demonstrated in response to Valsalva
in healthy individuals. Furthermore, right anterior cingulate activation has been well established
in the context of sympathetic activation, stress and tasks that facilitate a tachycardic
response12,30,31. In the context of clinical populations, Critchley et al., tested patients with focal
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damage involving the ACC and revealed that each patient had abnormal autonomic
cardiovascular responses with blunted autonomic arousal31. In the study by Critchley et al., the
level of cortical activity and morphology in the cingulate cortices also appeared to be affected in
patients with pure autonomic failure32. Moreover, in the current study, during the blood pressure
overshoot of phase IV of the Valsalva (an adrenergic phase of the maneuver), the hippocampus
remained significantly more activated in healthy controls relative to NOH patients. Interestingly,
in another study, regional cerebral blood flow as measured by MRI arterial spin labelling also
highlighted a significant role of the hippocampus during phase IV. The results revealed that
regional cerebral perfusion of the hippocampus was significantly correlated with baroreflex
sensitivity in that impaired baroreflex sensitivity was related to brain hypoperfusion33. Overall,
the data in the current study support current literature highlighting a role of the cingulate,
thalamus and hippocampus in autonomic regulation, and go on to further suggest impairment of
these regions in autonomic failure.

2.4.2

Altered autonomic afferent signals

Reduced functional cortical activation in these patients may be evidence of reduced autonomic
afferent information to structures involved in autonomic control. Representation of afferent
information within the central autonomic network has been established in both animal and
human research. In animals, the use of axonal radiotracers such as horseradish peroxidase has
revealed direct and extensive brainstem-cortical and cortical-cortical projections between
structures intricately related to autonomic regulation34–37. Furthermore, in humans,
somatosensory stimulation of forearm muscle afferents revealed afferent representation within
the anterior and posterior cingulate cortices, and bilateral posterior insula12. In the current study,
altered sympathetic afferent information in patients with peripheral autonomic lesions may result
in reduced central representation of those signals. Though the suggestion of reduced afferent
inputs within the central autonomic network is speculation, as this was not measured, the
possibility is strengthened by a lack of significant thalamic activation during Valsalva and deep
breathing. As a primary relay center in the brain, impaired activation of the thalamus may be
evidence of reduced afferent input in autonomic dysfunction, which in turn could further disrupt
thalamocortical projections to other cortical autonomic effector sites. The possibility of altered
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autonomic afferent signaling has also been posited in other studies involving individuals with
pure autonomic failure (PAF); a clinical population with selective peripheral denervation (i.e.
post-ganglionic) of the autonomic nervous system. Analysis of voxel-based morphology in PAF
patients identified regional reductions in grey matter volume in autonomic cortices relative to
controls32. This potential mechanism may be supported because despite the considerable level of
morbidity, these patients in general still have normal life expectancies. Therefore, as a direct
result of long-term peripheral autonomic denervation, patients with peripheral autonomic
denervation may experience cortical reorganization secondary to prolonged deafferentation,
similar to that previously reported38.
Overall, in the current study there is evidence to suggest that even in peripheral autonomic
disorders, there is also impairment of higher central autonomic networks specifically related to
sympathetic regulation. Conversely parasympathetic regulation did not produce any specific
differences in the controls versus the NOH group with respect to the functioning of the CAN. In
itself these data would argue that this is an important pathophysiological finding in patients with
NOH. Issues such as compensation or de-compensation within the very complex CAN would be
one important reason for our differential findings. For example, it may be that compensation
from a presumed normal CAN with respect to parasympathetic innervation to cardiovascular
structures is less profound than that of sympathetic function. In these patients the importance of
adrenergic function to attempt to maintain postural normotension is an important factor
especially from a clinical perspective as orthostatic blood pressure reduction has severe clinical
consequences (i.e. syncope). Finally, these data are significant as these patients are an important
clinical group with severe neurological impairment in the ANS. Such studies will be important to
inform this clinical situation potentially from both a prognostic and diagnostic standpoint.
Ultimately these data provide important insight into our understanding of the pathophysiology of
NOH in peripheral autonomic disorders.
Acknowledgements: This work was partly funded by the Canada First Research Excellence
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CHAPTER 3

3

Cerebellar impairment during an orthostatic challenge in patients with neurogenic
orthostatic hypotension2

3.1

Introduction
Neurogenic Orthostatic Hypotension (NOH) is a cardinal feature of autonomic

dysfunction. NOH is clinically defined as a sustained reduction in systolic blood pressure (SBP)
≥30 mmHg or diastolic blood pressure of ≥15 mmHg within 3 minutes of standing or head-up tilt
performed at 60° without an appropriate compensatory postural tachycardia1. NOH is unique in
that the orthostatic component relates to an excessive BP drop associated with an upright or
standing position and the neurogenic component highlights a failure of the autonomic nervous
system to reflexively increase sympathetic outflow to counteract the BP drop. Regulation of
arterial BP has been well established. In brief, blood pressure is mediated through an intricate
arterial baroreflex-mediated circuit initiated through baroreceptor stretch receptors primarily
located in the carotid sinus and aortic arch. During a state of hypotension, reduced afferent
signaling to the nucleus tractus solitarius in the brainstem facilitates a cascade of inhibitory and
excitatory signals, which ultimately increase sympathetic vasoconstrictor tone and tachycardia to
help maintain blood pressure 2. In addition to feedback mechanisms, feedforward or “central
command” mechanisms also contribute to long- and short-term regulation of the cardiovascular
system3. Specifically, the central autonomic network (CAN) includes a network of cortical,
subcortical and brainstem regions that have been implicated in neurovascular control. Regions
such as the cingulate cortices, insula, hippocampus, cerebellum and medial prefrontal have all
demonstrated significant contributions to the cardiovascular changes that occur in response to
various stressors4,5.

2

A version of this chapter has been published. Used with permission from Elsevier, Inc.
Baker J, Paturel J and Kimpinski K. (2019). Cerebellar impairment during an orthostatic challenge in patients with
neurogenic orthostatic hypotension. Clin Neurophysiol. 130(1):189-195
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Additionally, in clinical models such as stroke and lesion studies, damage to these areas results
in autonomic dysfunction6–8. Finally, a number of cortical and subcortical regions within the
CAN have specifically been implicated in baroreflex functioning. For example, clusters of
baroreceptor cells have been identified in the insula of rats9 and monkeys10, and posterior insular
lesions result in altered baroreceptor gain11. In humans, CAN regions such as the insula,
cingulate cortices, thalamus and cerebellum have also been evident during an orthostatic
challenge elicited through lower-body negative pressure12. Therefore, the purpose of the current
study was to compare activation patterns within the CAN in patients with NOH versus healthy
age-matched controls during an orthostatic challenge.

3.2
3.2.1

Methods
Patient and control groups

Fifteen healthy, age-matched controls (61±14 years; females: 8) and 15 patients diagnosed with
Neurogenic Orthostatic Hypotension (NOH) (67±6 years; females: 6) (p=0.12) completed the
following study. NOH was defined as a reduction in SBP ≥30 mmHg within 3 minutes of headup tilt (HUT) without an appropriate compensatory postural tachycardia as determined by the
∆HR/∆SBP ratio13. As an additional assessment of autonomic dysfunction, all patients also had
absent adrenergic phases (late phase II and phase IV) in response to the Valsalva maneuver. Prior
to testing, all diagnoses were clinically confirmed by a Neurologist with specialty training in
autonomic dysfunction (KK). Patients with central autonomic neurodegenerative disorders were
not included in the present study to eliminate any potentially confounding variables associated
with such central pathologies. Therefore, the NOH cohort was comprised of patients with
evidence of peripheral autonomic denervation only (pure autonomic failure, n=3; Parkinson’s
Disease + NOH, n=7; idiopathic NOH, n=5). In the current study, patients were categorized as
idiopathic NOH if there was considerable orthostatic hypotension, along with gastrointestinal
issues or other questionable phenomenon such as olfactory impairment, while not meeting
criteria for other alpha-synucleinopathies. As such, the latter diagnosis over time may be clearer
as the patient can develop a more specific diagnosis. In contrast, those diagnosed with PAF have
maintained a purely peripheral autonomic failure without any evidence of other pathology for an
extended period of time. Quantitative sudomotor axon reflex testing was performed on all
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patients to provide clinical evidence of peripheral denervation. Patients were excluded if there
was evidence of any peripheral nerve injury unrelated to their diagnosis of autonomic
dysfunction including diabetic neuropathies in any form. Healthy participants were examined to
confirm the absence of any neurological conditions including any autonomic dysfunction.
Healthy participants were also excluded if they fell under any one of the following categories: i)
pregnant or lactating females, ii) clinically significant coronary artery disease, iii) concomitant
therapy with anticholinergic, alpha- and beta-adrenergic antagonists or other medications which
could interfere with autonomic functioning, and iv) failure of other organ systems or systemic
illness that could affect autonomic function or participants’ ability to cooperate. All laboratory
data were collected in the Autonomic Disorders Laboratory at University Hospital, London,
Ontario. All functional imaging data were collected at Robart’s Research Institute Centre for
Functional and Metabolic Imaging at The University of Western Ontario. Ethical approval was
obtained from the Health Science Research Ethics Board at Western University, and informed
consent was obtained from all participants prior to any and all testing.

3.2.2

Autonomic testing

All participants underwent a battery of standardized and validated tests of autonomic function,
namely the autonomic reflex screen (ARS)14,15. Quantitative sudomotor axon reflex test
(QSART): QSART provided an assessment of post-ganglionic sympathetic function from four
standard sites (forearm, proximal leg, distal leg and foot). Beat-to-beat blood pressure and heart
rate responses to Valsalva and head-up tilt provided an assessment of adrenergic function. In
addition, all participants underwent Lower-body negative pressure (LBNP) as an additional
orthostatic challenge. Following a minimum baseline period of 15 minutes in the supine position,
LBNP was conducted at a pressure of -35 mmHg for 5 minutes, followed by a 5-minute recovery
period. All healthy participants completed 5-minutes of LBNP at -35 mmHg. In contrast, due to
the nature of the disease and the marked blood pressure drops in the patient group, in some cases
the negative pressure needed to be reduced to ensure blood pressure did not drop below a certain
threshold. On average, patients with NOH completed 5-minutes of LBNP at a negative pressure
of 27 mmHg. All patient started at -35mmHg, however if SBP dropped <65 mmHg, negative
pressure was reduced to ensure BP would plateau and not continue to drop. In the lab, beat-to-
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beat blood pressure (BP) and heart rate (HR) responses during all tests were continuously
measured and recorded using a BMEYE Nexfin device (Amsterdam, The Netherlands) and an
electrocardiography (ECG) device (Model 3000 Cardiac Trigger Monitor, IVY Biomedical
Systems, Inc., Branford, CT) with ECG electrodes (Ambu® Blue Sensor SP, Glen Burnie, MD),
respectively. All recordings were made using WR TestWorksTM software (WR Medical
Electronics Co., Stillwater, MN). Participants repeated the LBNP and VM protocol during a
functional MRI.

3.2.3

Neuroimaging data acquisition

All imaging data were collected using a whole body 3T imaging system with a 32-channel head
coil (Magnetom Primsa, Siemens Medical Solutions, Erlangen, Germany). A 3D MPRAGE
sequence was used to acquire a high-resolution T1-weighted structural at the beginning of the
scanning session (sagittal, matrix 256x240 mm, voxel resolution 1.0x1.0x1.0 mm, 1 mm slice
thickness, no gap, flip angle 9 degree, TE: 2.98 ms, TI: 900 ms, TR: 2300 ms). Blood oxygen
level-dependent (BOLD) signals were acquired using a T2- weighted gradient echo-echo planar
imaging pulse sequence with the following parameters: TE: 30ms; FOV: 240x240 mm; flip
angle: 40 degrees; multiband acceleration factor: 4. Forty-eight interleaved axial slices (3.0x3.0
mm in-plane voxel resolution, TR: 1000 ms) were acquired in each volume. Participant
completed one round of LBNP and 3 Valsalva maneuvers (VM) during a functional scan of their
brain. LBNP: Following a 60 second baseline, LBNP was initiated for 5-minutes following by a
5-minute period with LBNP off (660 volumes). Valsalva maneuver: Following a 60-second
baseline, participants completed 3 VM’s (15 seconds each), with 120 seconds of rest in between
each trial (465 volumes). The first 2 volumes of each test were discarded from analysis to allow
for an equilibrated MRI signal. To minimize head movement, each participant’s head was placed
in a cradle packed with foam padding. In addition, all participants practiced stabilizing
themselves on the foot plates within the lower-body negative pressure box, to minimize
movement when negative pressure was manipulated. Finally, all participants practiced
performing the VM while being supervised to ensure minimal head movement during the
maneuver. Beat-to-beat heart rate was recorded from a continuous signal derived from an MRIcompatible pulse oximeter (Nonin Medical, 8600FO MRI, Plymouth, MN) attached to the index
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finger of each participant’s left hand when possible. In the presence of a significant tremor (i.e.
in PD+NOH patients), pulse oximetry was obtained from the hand with less potential for
movement. All hemodynamic recordings were collected using WR TestWorks™ software (WR
Medical Electronics Co., Stillwater, MN).

3.2.4

Neuroimaging data analysis

Raw fMRI data were analyzed using SPM12 (Wellcome Department of Imaging Neuroscience,
London, UK). All functional images were realigned using a rigid body transformation to correct
for head motion using the mean functional image. All images were co-registered with the T1weighted scan, normalized to Montreal Neurological Institute (MNI) space and smoothed with a
Gaussian kernel (FWHM=6 mm). A high pass filter with 128-second cut-off was applied to
reduce low frequency noise.
Two levels of analysis were performed. In the first level of analysis, individual design matrices
of each protocol (LBNP and VM) were constructed modelled by a box-car and combined with a
canonical hemodynamic response function. A statistical parametric map was created on a voxelby-voxel basis using the General Linear Model 16. The LBNP protocol was broken down into
periods of rest, LBNP and recovery. Rest periods included the first minute prior to LBNP and the
last minute of the protocol. Brain activation patterns during LBNP were assessed during the final
60 seconds, when sympathetic activation should be the greatest. Finally, the first 30-seconds
following LBNP were analyzed as a recovery phase. Similarly, the VM protocol was assessed as
periods of rest and VM. All contrasts (VM, LBNP and LBNP-recovery) were compared against
their respective rest periods. In a second-level analysis, each individual’s contrast for each
protocol was entered into a 2-sample independent t-test to compare differences between patients
and controls. Comparisons of the BOLD responses were corrected for multiple comparisons
(family-wise error (FWE) <0.05). In some cases, a more lenient threshold of p<0.001,
uncorrected was used with a cluster threshold of 10 voxels.

3.2.5

Regions-of-Interest analysis

Regions of interest (ROI) were determined based on previous work highlighting regions of the
central autonomic network. These a priori ROI included the bilateral insula, bilateral anterior and
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posterior cingulate, bilateral hippocampus, bilateral thalamus and bilateral cerebellum. All ROI
masks were created using WFU_Pick Atlas toolbox version 1.217,18.

3.2.6

Statistical analysis

Physiological data are presented as mean ± standard deviation. Autonomic parameters between
patients and age-matched controls were compared using an independent t-test. All tests were 2tailed with a p-value <0.05 to denote significance. All statistical analyses were performed using
SPSS statistical software, Version 22.0. Manufactured by International Business Management
(IBM) Corporation (SPSS Inc. Chicago, IL).

3.3
3.3.1

Results
QSART and hemodynamic findings

Compared to healthy controls, patients had significantly lower average sweat volumes at the
proximal (1.23±0.93 µL vs. 0.47±0.47 µL, respectively) and distal leg (1.23±0.86 µL vs.
0.44±0.40 µL, respectively) (p<0.01), and a trend toward lower sweat volumes at the forearm
(1.31±0.72 µL vs. 0.81±0.69 µL, respectively) (p=0.07). Sweat volumes at the foot were not
significantly different (0.91±0.68 µL vs. 0.65±0.50 µL, respectively) (p=0.24). During both HUT
and LBNP in the lab session, patients with NOH had significantly larger blood pressure drops
with significantly smaller compensatory tachycardias versus healthy controls (Table 3.1)
(p<0.01). LBNP during the functional imaging session revealed similar significantly different
HR responses. Hemodynamic changes in response to the LBNP between LAB and MRI sessions
revealed no significant differences (Table 3.1).

3.3.2

Functional BOLD responses

During LBNP, healthy controls showed significant activation relative to rest in the bilateral
insula (Figure 3.1), bilateral thalamus, anterior cingulate cortex, and bilateral cerebellum (Table
3.2) (p<0.05). Similarly, patients with NOH had significant activation in the bilateral insula
(Figure 3.1) and left thalamus (Table 3.2) (p<0.05). During LBNP, controls had significantly
greater activation in the bilateral cerebellum compared to patients (Table 3.2; Figure 3.2)
(p<0.05). To investigate the role of the cerebellum in a different test of baroreflex regulation,

55

both groups completed a series of VM. Similar to LBNP, controls also had significantly greater
activation in the bilateral cerebellum in response to Valsalva maneuver (Figure 3.2) (p<0.05).
Finally, during the recovery phase of LBNP, both controls and patients had significant activation
in the bilateral insula and right cerebellum (Table 3.3; Figure 3.3) (p<0.05). Patients also had
significant activation in the right anterior and midline posterior cingulate cortices (Table 3.3). No
significant differences were found between controls and patients during the LBNP-recovery
phase.

Table 3.1 Laboratory and MRI autonomic testing.
Orthostatic Testing:
Control (n=15)
Mean ± SD
LAB Head-up Tilt
Resting Heart Rate (bpm)
61.6±9.7
∆Heart Rate
20.2±7.9
Resting SBP (mmHg)
117.1±14.9
∆SBP (mmHg)
-21.0±8.2
∆HR/∆SBP ratio during
1.1±0.5
HUT
LAB LBNP
Resting Heart Rate (bpm)
∆Heart Rate
Resting SBP (mmHg)
∆SBP (mmHg)
∆HR/∆SBP ratio during
HUT

65.9±8.8
19.3±8.5
105.3±11.7
-23±6
0.87±0.4

Patient (n=15)
Mean ± SD

p-value

70.5±11.3
8.9±6.7
146.3±25.2
-79.7±25
0.14±0.2

0.03
0.002
0.001
<0.001
<0.001

73.6±9.1
7.0±4.3
148.4±27.8
-57.7±22.6
0.14±0.14

=0.1
<0.001
=0.003
<0.001
<0.001

MRI LBNP
Resting Heart Rate (bpm)
69.9±11.6
74.8±8.4
=0.228
∆Heart Rate
17.6±8.9
7.1±3.2
<0.001
Abbreviations: SBP, systolic blood pressure; LBNP, lower-body negative pressure; MRI,
magnetic resonance imaging; ∆, change; QSART, quantitative sudomotor axon reflex test; SD,
standard deviation
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Table 3.2 Brain regions activated during LBNP in healthy controls and NOH patients.
Controls had significantly greater activation in the cerebellum relative to patients.
Controls LBNP
Region
Side
Voxel #
T-score
p-value
Thalamus
Insula
ACC
Cerebellum

Patient LBNP
Insula
Thalamus

L
R
L
R
R
Midline
R
L

85
126
163
141
153

L
R
L

81
73
64

235

Controls activation>Patients activation during LBNP
Cerebellum
L
65
R
65

11.55
8.74
9.36
5.81
6.27
7.33
6.78
6.67

P<0.05
P<0.05
P<0.05
P<0.05
P<0.05
P<0.05
P<0.05
P<0.05

6.83
5.51
7.20

P<0.05
P<0.05
P<0.05

4.58
4.53

P<0.05
P<0.05

Controls activation>Patients activation during VM
Cerebellum
L
49
8.37
P<0.05
Cerebellum
R
186
8.28
P<0.05
Cerebellum
L
80
8.74
P<0.05
Abbreviations: LBNP, Lower body negative pressure; NOH, Neurogenic Orthostatic
Hypotension; VM, Valsalva Maneuver; L, Left; R, Right.
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Table 3.3 Brain regions of activation post-LBNP during recovery phase in healthy controls
and NOH patients. No significant differences between controls and patients were found.
Controls – LBNP recovery
Region
Side
Voxel #
T-score
p-value
Insula
Cerebellum
Patients – LBNP recovery
Insula

R
L
R

82
78
131

6.48
6.22
6.66

P<0.05
P<0.05
P<0.05

L
125
6.40
P<0.05
R
101
5.81
P<0.05
ACC
R
228
6.73
P<0.05
PCC
Midline
63
5.40
P<0.05
Cerebellum
R
193
6.80
P<0.05
Abbreviations: LBNP, Lower body negative pressure; NOH, Neurogenic Orthostatic
Hypotension; L, Left; R, Right.
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Figure 3.1 Cortical activation patterns during LBNP.
No significant differences between controls and patients during LBNP. Both groups had
similar activation in the bilateral insula. Abbreviations: LBNP, Lower body negative pressure; BOLD,
blood oxygen level dependent.
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Figure 3.2 Comparison of cerebellar changes during VM and LBNP.
Controls had greater activation in the cerebellum during LBNP and VM relative to patients.
Abbreviations: LBNP, Lower body negative pressure; BOLD, blood oxygen level dependent; VM, Valsalva
maneuver.
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Figure 3.3 Brain activation during post-LBNP recovery phase.
During the post-LBNP recovery no significant differences were found between healthy
controls and patients. Both controls and patients had activation in the bilateral insula and
cerebellum. Abbreviations: LBNP, Lower body negative pressure; BOLD, blood oxygen level dependent.
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3.4

Discussion

Neurogenic orthostatic hypotension (NOH) is a cardinal feature of autonomic failure. During an
orthostatic challenge such as head-up tilt or lower-body negative pressure (LBNP), patients
experience a significant and persistent blood pressure drop without evidence of an appropriate
compensatory sympathetic response to counter the blood pressure fall. During an orthostatic
stressor such as LBNP, regions within the central autonomic network (CAN) such as the insula
and cerebellum have been largely implicated for their involvement in mediating cardiovascular
responses. Our results reveal three important findings in the context of NOH and CAN
activation: 1) Central activation patterns in healthy older controls are consistent with previous
literature highlighting a role of the insula and cerebellum during an orthostatic challenge such as
LBNP. 2) Interestingly, patients with autonomic dysfunction revealed similar insular activation
patterns; however, there was significantly less cerebellar activation during LBNP. 3) To
investigate the role of the cerebellum in a different test of baroreflex regulation, both groups
completed a series of Valsalva maneuvers. Similar to LBNP, patients had significantly less
cerebellar activation during VM compared to healthy controls.

The role of the cerebellum in movement coordination and balance/vestibular regulation has been
well established. However, in the context of the central autonomic network, the cerebellum has
arguably received less attention than cortical sites. In human and animal studies alike, a growing
body of literature has emerged highlighting a number of autonomic functions that appear to
involve pathways through the cerebellum19, including postural control of blood pressure and
heart rate20. In the present study, the cerebellum along with the insular cortex and thalamus were
significantly activated in healthy individuals during a LBNP. These finding corroborate much of
the previous work that has highlighted these same areas during both an orthostatic challenge12,21
and during other mental and physical stressors that facilitate blood pressure changes. For
example, in an exercise of mental and physical stress (hand-grip), increased regional cerebral
blood flow (rCBF) in the cerebellum, right anterior cingulate and right insula covaried with mean
arterial pressure. Similarly, rCBF in the pons, cerebellum and right insula covaried with heart
rate22. Interestingly, cerebellar activation was not evident in patients with NOH during the same
orthostatic challenge. The cerebellum and vestibular system are important to maintaining a stable
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blood pressure and respiration during postural changes. The cerebellum projects to several
brainstem structures, including the nucleus tractus solitarius (NTS), parabrachial nucleus 23 and
rostral ventrolateral medulla (RVLM)24, in addition to, the rostral portion of the inferior and
medial vestibular nuclei25,26. Together, these brainstem sites integrate vestibular information and
modulate sympathetic reflexes, which in turn regulate postural control of blood pressure.
The properties of the vestibulo-sympathetic reflex have been studied in several animal models.
For example, electrical and chemical stimulation of cerebellar regions that process vestibular
signals, including the fastigial nucleus27,28 and posterior cerebellar cortex29,30 elicit marked
cardiovascular responses via direct or indirect connections with the aforementioned brainstem
structures. Furthermore, during a postural change following removal of vestibular inputs, animals
with cerebellar lesions experienced more severe orthostatic hypotension than cerebellum-intact
animals31. Despite the severe blood pressure drops that patients with NOH experience,
paradoxically, approximately 50% of patients also have supine hypertension32. The fastigial
nuclei (FN) and cerebellar areas, play an important role in limiting blood pressure extremes such
as that seen in hypo- and hypertension, and damage to these areas results in hypotension 33.
Furthermore, in evaluating the FN neural activity during blood pressure alterations via the
modified oxford method, FN neural activity increases during hypotension34. These findings
suggest that the FN may play an important compensatory role during large blood pressure
changes by sympatho-excitatory and inhibitory processes. Given the propensity of the extreme
blood pressures seen in NOH patients, the lack of significant cerebellar activation and the
evidence supporting a role of cerebellar structures in attenuating such blood pressure extremes, it
remains plausible that sympatho-excitatory reflexes facilitated by the cerebellum during a
postural change may be absent or disrupted in NOH. Together, these data may provide some
insight and evidence for this region and its involvement in the pathophysiology of NOH.
Finally, to investigate the role of the cerebellum in a different test of blood pressure regulation,
both groups completed a series of Valsalva maneuvers. Similar to an orthostatic challenge,
during the VM there is a precipitous drop in blood pressure that would normally be arrested via
reflexive sympathetic vasoconstriction and tachycardia. In patients with NOH, the
adrenergically-mediated phases of the maneuver are absent. As a result, patients demonstrate a

63

blood pressure profile that reveals a similar precipitous and persistent drop in blood pressure to
that of Head-up Tilt, until the maneuver is completed. Similar to LBNP, patients had
significantly less cerebellar activation during VM as compared to healthy controls. Overall, these
data further support a role of the cerebellum in mediated important sympatho-excitatory
processes during significant blood pressure perturbations.

3.4.1

Study limitations

Our results reveal important findings regarding the role of the cerebellum in the pathophysiology
of NOH. Despite these unique findings, the current study contains the following limitations: 1)
Due to the nature of blood pressure dysfunction seen in this clinical group, in some cases the
negative pressure that was used during LBNP was less than that in healthy controls. Despite a
reduced negative pressure, patients still showed activation within the insula and thalamus, similar
to that of healthy controls. Furthermore, despite the lower negative pressure in some cases, all
patients still demonstrated a significant blood pressure drop even at a reduced pressure. 2) Blood
pressure was not measured during the MRI session. MRI compatible blood pressure monitoring
typically involves invasive techniques such as insertion of an arterial line. Due to the invasive
nature of this technique we opted to use heart rate changes as a surrogate indicator of the
autonomic changes. Heart rate changes in response to LBNP and Valsalva were not significantly
different between lab and MRI recording sessions. Furthermore, all study participants
experienced the same negative pressure during the MRI as was performed during the lab.
Therefore, despite the lack of a direct blood pressure measure in the MRI, we assume the
cardiovascular and autonomic changes were similar. 3) In previous studies, LBNP is typically
applied in several repeated bouts ranging from 30-45 seconds. In the current study, we applied a
single-epoch design to replicate the head-up tilt protocol that has been validated and standardized
in clinical autonomic disorders. Even though, multiple epochs are typically used, single-epoch
studies have been previously used with certain protocols that cannot use repeated stimuli, such as
pain studies 35. Furthermore, single-epoch fMRI has been previously validated against multiple
epochs of stimulation, with results that yield similar activation patterns36. 4) The sweat responses
to QSART did not reveal a significant difference between patients and controls at the foot.
However, these values are still considered reduced relative to normative data, and thus these data
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support the presence of post-ganglionic sympathetic denervation in the pathophysiology of NOH.
5) Other more direct measures of cerebral circulation (i.e. transcranial doppler, regional cerebral
blood flow, etc.) were not implemented in the current study. Certainly, these additional
measurements would have been helpful to address questions pertaining to changes in brain blood
flow and perfusion and could be considered in future studies.

3.5

Conclusion

The purpose of the current study was to compare activation patterns within the CAN in patients
with Neurogenic Orthostatic Hypotension versus healthy age-matched controls during an
orthostatic challenge. Our results reveal that patients with NOH have significantly less activation
in the cerebellum during an orthostatic challenge compared to healthy controls. Furthermore,
patients also had significantly less cerebellar activation during VM, which also involves
baroreflex-mediated increases in sympathetic tone. Therefore, the results suggest that regions of
the cerebellum that modulate vestibulo-sympathetic reflexes, which are important in blood
pressure adjustments during postural alterations, as well as baroreflex mediated influences on
sympathetic activation may be disrupted in patients with NOH.
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CHAPTER 4

4

Reduced brainstem functional connectivity in patients with peripheral autonomic
failure3

4.1

Introduction

Neurogenic Orthostatic Hypotension (NOH) is a cardinal feature of autonomic failure. NOH
is clinically defined as a sustained reduction in blood pressure ≥30 mmHg during an orthostatic
challenge such as standing from a lying or seated position or during head-up tilt performed at a
minimum 60° angle from the horizontal without an appropriate compensatory postural
tachycardia1. NOH occurs due to a failure of the sympathetic reflexes that would normally
counteract blood pressure perturbations through reflexive tachycardia and vasoconstriction.
General classifications of NOH are made based on where failure of the sympathetic efferent
signaling pathway occurs i.e. before or after the autonomic ganglia. For example, in Parkinson’s
Disease (PD) with autonomic failure, Pure Autonomic Failure (PAF) and diabetic autonomic
neuropathies, the lesion site is considered to be post-ganglionic.
Autonomic homeostasis is dependent upon several brainstem nuclei, including the nucleus
tractus solitarius (NTS) and rostral and caudal portions of the ventrolateral medulla. For
example, the NTS receives afferent input and through a cascade of excitatory and inhibitory
signaling makes beat-to-beat adjustments to efferent autonomic outflow. Moreover, various
autonomic brainstem nuclei have been shown to project to both cortical and subcortical regions
and have also been shown to receive input from higher cortical structures 2–4. Through
advancements in neuroimaging, several cortical and subcortical structures including the insula,
hippocampus, cerebellum, thalamus and cingulate cortices, have been well established as
components of the central autonomic network (CAN) 5–8.

3

A version of this chapter is currently under review for publication.
Baker J and Kimpinski K (2019). Reduced brainstem functional connectivity in patients with peripheral autonomic
failure. NeuroImage: Clinical (under second review)
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Importantly, studies have not only tested different modalities, but have also correlated brain
activation patterns to hemodynamic responses and direct measures of sympathetic activity.
Together, these studies have identified structures of the CAN that contribute specifically to
sympathetic and parasympathetic regulation.
Based on the aforementioned pre- versus post-ganglionic classification of autonomic failure, it
could be thought that brainstem nuclei and structures of the CAN would remain functionally
intact. However, our laboratory recently demonstrated that despite post-ganglionic pathology,
patients with NOH show evidence of reduced activation in regions of the CAN during autonomic
maneuvers9,10.
Despite the brainstem being the main region for central integration of baro- and chemoreceptor
afferents, brainstem-to-brain connectomes have not been fully investigated. Specifically, the
evaluation of functional connectivity between the brainstem and regions of the CAN in
individuals with autonomic failure has yet to be studied. Therefore, the aim was to investigate
whether functional connectivity from the brainstem to cortical and subcortical structures differs
in patients with NOH secondary to autonomic failure as compared to their healthy counterparts.

4.2
4.2.1

Methods
Patient and control groups

The current study was comprised of fifteen healthy, age-matched controls (61±14 years; females:
8) and 15 patients diagnosed with NOH (67±6 years; females: 6; p=0.12). The NOH cohort
consisted of patients with evidence of peripheral autonomic denervation only (PAF, n=4; PD
with autonomic failure, n=6; idiopathic NOH, n=5). All patients underwent a standard head-up
tilt (HUT) test and met the clinical criteria for NOH. On average patients had a resting heart rate
(HR) and systolic blood pressure (SBP) of 71±11 bpm and 146±25 mmHg, respectively. On
average, SBP dropped by 80±25 mmHg during HUT with an average HR change of 9±7 bpm. As
an additional assessment of autonomic dysfunction, all patients demonstrated absent adrenergic
phases (late phase II and phase IV) in response to the Valsalva maneuver and cardiovagal
impairment evidenced by a reduced Valsalva ratio (1.2±0.1). Furthermore, to provide clinical
evidence of post-ganglionic impairment, all patients underwent quantitative sudomotor axon
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reflex testing (QSART) from four standard sites (forearm, proximal leg, distal leg and foot).
Sudomotor dysfunction was scored as follows: 1= reduced sweat response at a single site,
2=absent response at a single site, 3=absent response at 2 or more sites. The composite
autonomic scoring scale (CASS) was used to quantify the severity and distribution of autonomic
failure across three domains: sudomotor (0-3), cardiovagal (0-3) and adrenergic (0-4)11. On
average patients scored a 2/3, 2/3 and 4/4, respectively, resulting in a total CASS of 8/10
indicative of severe and widespread autonomic dysfunction.
Patients with neurodegenerative disorders related to a central autonomic pathology (i.e. Multiple
System Atrophy) were excluded from the present study to eliminate any potentially confounding
variables associated with such central pathologies (i.e. brain atrophy). Moreover, patients were
excluded if there was evidence of any peripheral nerve injury unrelated to their diagnosis of
autonomic dysfunction including diabetic neuropathies in any form. In the current study, Pure
autonomic failure (PAF) was characterized by orthostatic hypotension along with more
widespread autonomic failure, including sympathetic and parasympathetic dysfunction. In
addition, PAF patients showed no clear identifiable underlying cause, no other neurological
features present and no features to suggest central involvement. PAF patients had maintained a
purely peripheral autonomic failure without any evidence of other pathology for an extended
period of time. In contrast, a diagnosis of idiopathic NOH was given if, again, there was
evidence of orthostatic hypotension, along with gastrointestinal issues or other questionable
phenomenon such as olfactory impairment, but not meeting criteria for other alphasynucleinopathies. A Neurologist (KK) with specialty training in autonomic dysfunction
clinically confirmed all testing and made the final diagnoses.
All healthy participants were examined to confirm the absence of any neurological conditions
including autonomic dysfunction. Additional exclusion criteria including the following
categories: i) pregnant or lactating females, ii) clinically significant coronary artery disease, iii)
concomitant therapy with anticholinergic, alpha- and beta-adrenergic antagonists or other
medications which could interfere with autonomic functioning, and iv) failure of other organ
systems or systemic illness that could affect autonomic function or participants’ ability to
cooperate.
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All laboratory data were collected in the Autonomic Disorders Laboratory at University
Hospital, London, Ontario. All functional imaging data were collected at Robart’s Research
Institute Centre for Functional and Metabolic Imaging at The University of Western Ontario.
Ethical approval was obtained from the Health Science Research Ethics Board at Western
University, and informed consent was obtained from all participants prior to testing.

4.2.2

Neuroimaging data acquisition

All imaging data were collected using a whole body 3T imaging system with a 32-channel head
coil (Magnetom Primsa, Siemens Medical Solutions, Erlangen, Germany). At the beginning of
the scanning session, a 3D MPRAGE sequence was used to acquire a high-resolution T1weighted structural (sagittal, matrix 256x240 mm, voxel resolution 1.0x1.0x1.0 mm, 1 mm slice
thickness, no gap, flip angle 9°, TE: 2.98 ms, TI: 900 ms, TR: 2300 ms). Blood oxygen leveldependent (BOLD) signals were acquired using a T2- weighted gradient echo-echo planar
imaging pulse sequence with the following parameters: TE: 30 ms; FOV: 240x240 mm; flip
angle: 40 degrees; multiband acceleration factor: 4. Forty-eight interleaved axial slices (3.0x3.0
mm in-plane voxel resolution, TR: 1000 ms) were acquired in each volume. To help minimize
head movement each participant’s head was placed in a cradle packed with foam padding.

4.2.3

Neuroimaging protocol

Participants completed 5 minutes of rest followed by three Valsalva maneuvers (VM) during a
functional scan of their brain. Rest: For all participants, the resting period consisted of 5 minutes
during which, all participants were instructed to remain still with their eyes closed, but not to fall
asleep. Valsalva maneuver: The Valsalva session was modeled as a blocked design switching
between periods of rest and the maneuver. Following a 1-min baseline, participants were
instructed to take a deep breath in, followed immediately by an exhalation to be maintained at an
expiratory pressure of 40 mmHg, held for 15-seconds. The maneuver was repeated three times
separated by a 2-min (120 sec) rest in between trials. The first 10 seconds immediately following
release of the maneuver was recorded as a recovery period. The remaining 110 seconds were
recorded as a rest period to allow for hemodynamics to return to baseline prior to performing
another Valsalva. Together, the Valsalva scanning duration was 465 seconds. All participants
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were provided real-time visual feedback of their expiratory pressure to ensure the maneuver was
performed correctly. To further minimize head movement during VM, all participants practiced
the maneuver prior to scanning while being supervised. In addition, during the scanning session,
an MRI technician provided feedback if there was excessive movement, in which case the
maneuvers were repeated. Beat-to-beat heart rate was recorded from a continuous signal derived
from an MRI-compatible pulse oximeter (Nonin Medical, 8600FO MRI, Plymouth, MN). All
hemodynamic recordings were collected using WR TestWorks™ software (WR Medical
Electronics Co., Stillwater, MN).

4.2.4

Neuroimaging analysis

All imaging data were analyzed using the Conn functional connectivity toolbox (v18a) available
through SPM12 (Wellcome Department of Imaging Neuroscience, London, UK) using a
MATLAB R2016b interface (Mathworks, Natick, MA). Preprocessing steps included
realignment, unwarping and slice-time correction. All structural and functional images were
segmented in grey matter, white matter and cerebral spinal fluid, normalized to Montreal
Neurological Institute (MNI) space and smoothed with a Gaussian kernel (Full-Width HalfMax=6 mm). In addition to realignment, the ART-based scrubbing method was further used to
detect outlier volumes with high motion (ART parameters: 2-mm subject motion threshold and a
global signal threshold set at Z=9). Nuisance variables including: 6 realignment parameters, first
5 principle components from the white matter and CSF and the outlier volumes from the
scrubbing procedure were then regressed out of the signal. The data were linearly detrended and
a band-pass filter of 0.008 to 0.09Hz was applied. A brainstem mask was used as the brainstem
seed source, and all areas for connectivity were defined on a regions-of-interest (ROI) basis
using an ROI-to-ROI approach at rest and during Valsalva maneuver. Cortical (91 ROIs) and
subcortical (15 ROIs) atlases from the Harvard-Oxford Atlas and cerebellum parcellation (26
ROIs) atlas from AAL atlas were used in the ROI analysis. In the first level analysis, ROI-toROI maps were generated for each individual during the predefined conditions. Individual
connectivity maps were created using the General Linear Model convolved with a canonical
hemodynamic response function. In the second-level analysis, a between-subjects contrast
(controls>patients [1, -1]; patients>controls [-1, 1]) was performed on the basis of a random-
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effects General Linear Model, with a seed-level correction for multiple comparisons (falsediscovery rate: p<0.05).

4.3
4.3.1

Results
ROI-to-ROI functional connectivity

Rest: Compared to patients with NOH, at rest controls had significantly greater brainstem
connectivity to the anterior cingulate cortex (ACC) (T-value: 4.29; p-FDR<0.001), left anterior
insula (T-value: 3.31; p-FDR<0.001), left putamen (T-value: 3.31; p-FDR<0.005) and bilateral
thalamus (TR-value: 3.83; TL-value: 4.25; p-FDR<0.001) (Figure 4.1). The effect sizes for the
aforementioned brainstem-to-ROI connectivities ranged from small to moderate (Figure 4.1).

Valsalva (VM): During VM, controls also showed significantly more connectivity between the
brainstem and both the left anterior (cerebellum 4/5) and bilateral posterior cerebellum
(cerebellar 9 and left cerebellar 6). Other cerebellar regions included brainstem-to-vermis
(Vermis 4/5, 6, 8, 9 and 10). Other brainstem-to-cortical and subcortical regions included:
bilateral putamen, posterior cingulate cortex, amygdala and medial prefrontal cortex (Figure 4.2).
The effect sizes were moderate-to-strong for each brainstem-to-ROI (Table 4.1). Moreover, there
was a significant negative correlation between the brainstem-cerebellar connectivity and the total
CASS (Table 4.2).

Valsalva recovery: During the recovery phase of the VM, controls had greater brainstem
connectivity to the left thalamus (4.17; p-FDR=0.02); PCC (3.32; p-FDR<0.05); right putamen
(3.28; p-FDR<0.05); right paracingulate gyrus (3.25; p-FDR<0.05) and left posterior cerebellum
(C9: 3.21; p-FDR<0.05). Similar to VM, the effect sizes for each brainstem-to-ROI was
moderate-strong (Figure 4.3).
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Table 4.1 Targets with greater brainstem functional connectivity during VM in healthy
controls
Brainstem Target
Side
T-value
P-FDR corrected
Effect Size
Cerebellum Lobule 9
R
5.29
<0.005
0.75
Cerebellum Lobule 6
L
4.82
<0.005
0.90
Cerebellum Lobule 9
L
4.53
<0.005
0.74
Vermis Lobule 4/5
4.31
<0.01
0.76
Cerebellum Lobule 4/5
L
3.97
<0.01
0.82
Vermis Lobule 6
3.88
<0.01
0.72
Vermis Lobule 8
3.86
<0.01
0.74
Putamen
L
3.78
<0.01
0.63
PCC
3.70
<0.01
0.68
Putamen
R
3.42
<0.01
0.59
Vermis Lobule 9
3.15
<0.05
0.64
Vermis Lobule 10
2.95
<0.05
0.47
Amygdala
L
2.91
<0.05
0.60
MPFC
2.82
<0.05
0.54
Abbrev. VM, Valsalva maneuver; L/R, left/right; PCC, posterior cingulate cortex

Table 4.2. Brainstem-cerebellar connectivity during VM correlates negatively with total
CASS.
C9-R
C9-L
C6-L C4/5-L
V4/5
V6
V8
V9
V10
Total
-0.725 -0.674 -0.738 -0.592
-0.626 -0.559 -0.589 -0.529 -0.594
CASS*
P-value
<0.001 =0.001 <0.001 =0.006
=0.003 =0.01 =0.006 =0.016 =0.006
* values represent r values
Abbrev: VM, Valsalva maneuver; CASS, composite autonomic scoring scale; C, Cerebellum;
V, Vermis;
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Brainstem

Effect Size

Target
(L) Putamen

0.26

(L) Thalamus

0.41

(R) Thalamus

0.34

ACC

0.36

(L) Ant. Insula

0.26

Figure 4.1. Brainstem functional connectivity at rest [controls>patients].
At rest, controls had significantly greater brainstem connectivity compared to patients with NOH.
Strength of connectivity is represented across a colour spectrum with red representing larger T-values
and stronger connectivity. Abbrev. L/R, left/right; ACC, anterior cingulate cortex; Ant, anterior; Thal,
Thalamus; ROI, region of interest
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Figure 4.2. Brainstem functional connectivity during Valsalva maneuver [controls>patients].
During Valsalva maneuver, controls had significantly more brainstem connectivity to the amygdala,
bilateral putamen, PCC, MPFC and cerebellum compared to patients. Strength of connectivity is
represented across a colour spectrum with red representing larger T-values and stronger connectivity.
Abbrev. L/R, left/right; PCC, posterior cingulate cortex; ROI, region of interest; MPFC, medial
prefrontal cortex
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Brainstem

Effect Size

Target
(R) Putamen

0.58

(L) Thalamus

0.68

PCC

0.63

(R) PaCiG

0.34

(L) Cerebellum 9

0.57

Figure 4.3. Brainstem functional connectivity during recovery phase of Valsalva maneuver
[controls>patients].
Controls had significantly more brainstem functional connectivity during the recovery phase of
Valsalva. Strength of connectivity is represented across a colour spectrum with red representing
larger T-values and stronger connectivity. Abbrev. L/R, left/right; PaCiG, paracingulate gyrus;
PCC, posterior cingulate cortex; ROI, region of interest
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4.4

Discussion

In the current study we compared functional connectivity measures between patients with
autonomic failure and age-matched controls at rest and during an autonomic challenge. Using the
brainstem as a seed source we found the following significant findings: 1) Patients with
autonomic failure showed significantly less brainstem connectivity to structures of the central
autonomic network throughout a state of rest and in response to a Valsalva maneuver. 2)
Brainstem-to-cerebellum connectivity was negatively correlated with the total CASS suggesting
individuals with more severe and widespread autonomic dysfunction have reduced brainstemcerebellar connectivity.
The cortical and subcortical structures found functionally linked to the brainstem represent well
recognized findings from neuroimaging and autonomic literature. In the current study, patients
had significantly less brainstem connectivity to key autonomic structures including the
cerebellum, thalamus, cingulate cortices, medial prefrontal and insula. These regions have all
been highly implicated in autonomic regulation both in animals and humans, and in health and
disease5,12. The thalamus plays a pivotal role as the primary relay site for information and has an
abundance of anatomical projections to cortical, subcortical and brainstem structures12,13.
Moreover, both the posterior and anterior cingulate cortices are key contributors to autonomic
regulation, specifically modulations of heart rate and blood pressure5,14,15. For example, the
anterior cingulate is commonly activated during maneuvers that elicit an increase in sympathetic
activity such as the Valsalva maneuver, maximal inspiratory apneas and lower-body negative
pressure. Furthermore, increased ACC activation has also been coupled with direct recordings of
sympathetic nerve activity16. This is important, as improper regulation of heart rate, blood
pressure and efferent sympathetic activity are cardinal features of autonomic failure. Moreover,
the insula cortex (IC) has been highly investigated in autonomic regulation. Anatomically, the
insula is reciprocally linked to brainstem autonomic nuclei4,17, which provides an anatomical
basis for autonomic influence. Functionally, the IC is extremely complicated. The IC has been
partitioned into anterior/posterior portions as well as lateralized into left and right, each
contributing separately to autonomic regulation. For example, stimulation of the rostral posterior
IC in rats induced tachycardia while bradycardia was elicited via caudal stimulation18 .

79

Furthermore, Zhang et al., (1998) demonstrated that damage to the left IC increased cardiac
baroreceptor gain with no effect on heart rate or blood pressure, while right IC lesions resulted in
increased baseline heart rate and blood pressure with no effect on gain19. Despite the complicated
nature of the IC it is nevertheless involved in autonomic regulation. Finally, the current results
extend beyond functional imaging studies, and coincides with existing functional connectivity
literature in healthy controls, which also report significant brainstem connectivity with the ACC,
thalamus, putamen and cerebellum20.
A second key finding highlighted significantly less functional connectivity between the
brainstem and the cerebellum/vermis during VM in patients with autonomic failure. The
cerebellum is a key central structure that is commonly seen in functional imaging studies
particularly studies involving blood pressure perturbations. Moreover, there is a growing amount
of evidence to support a key role for the cerebellum in regulating blood pressure and limiting
blood pressure extremes21,22. Therefore, the cerebellum may play a key role during the VM
where there are large blood pressure fluctuations, and absent compensatory responses in
autonomic failure. For example, patients demonstrate large blood pressure reductions during
early phase II of the maneuver without an appropriate sympathetically mediated late phase II
response. Similarly, following release of the maneuver, an additional burst of sympathetic
activation acts to increase blood pressure back to, or above baseline levels – a response that is
also absent in autonomic failure. Both responses require increased sympathetic activation to alter
blood pressure and this becomes important as the cerebellum is involved, in part, with
sympathetic activation through direct projections with brainstem nuclei, including the NTS and
RVLM23,24. Evidence of reduced brainstem connectivity to the cingulate, insula and cerebellum
coincide with imaging studies with concurrent recordings of sympathetic nerve activity that have
correlated these regions to increased sympathetic activity16.
Despite a patient sample consisting of autonomic failure involving post-ganglionic impairment,
the current results also suggest impaired functional connectivity between the brainstem and
autonomic brain structures. Recent advances in network sensitive neuroimaging techniques have
begun to identify distinct patterns of functional connectivity in various diseases25,26. As a result,
various hypotheses have emerged to explain the role neuronal networks may play in clinical
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progression of various diseases. Two disease-mechanism models have been hypothesized, which
may help explain the current results: 1. The Nodal stress model, and 2. Transneuronal spread.
The nodal stress model postulates that certain regions, or “nodes” within the brain that are
subject to heavy network trafficking may be more vulnerable to activity-related “wear and
tear”25,27. The brainstem is the primary site for afferent input and as such sends and receives
efferent and afferent information on a continuous basis to ensure proper neurovascular function.
In addition to afferent feedback, efferent signals from higher cortical and sub-cortical structures
also contribute to proper autonomic regulation through direct and indirect projections to the
brainstem13. Together the brainstem is a critical hub for autonomic inputs, and the abundance of
intra-network information may influence regional neurodegeneration that is activity-dependent.
In a disease that fails to properly regulate autonomic responses such as blood pressure, various
afferent and efferent inputs may overload brainstem networks in an attempt to rectify the failed
responses. However, even if the appropriate efferent signals can be sent, the post-ganglionic
lesion would interrupt the signal leading to more feedback, ultimately resulting in a viscous cycle
of chronic elevated activity and possibly an eventual pathological state.
The mechanism of transneuronal spread suggests that neurodegeneration between cortical
networks progresses via axonal connections28. Seeley et al., further suggest that disease
progression starts at a primary network (i.e. the brainstem) and is more likely to extend into
networks with stronger functional relationships29. This is important for two primary reasons.
First, the results demonstrate that the cortical regions that showed significant differences
between patients and controls were structures of the central autonomic network, and would
therefore have a strong functional and structural relationship with the brainstem. Second, this
model predicts that networks with shorter functional paths to the epicenter will be more
vulnerable once the disease is present30. Anatomically, the cerebellum not only has direct
projections with the brainstem but also demonstrates a relatively short functional pathway, and
the strength of the brainstem-cerebellum connectivity was negatively correlated with autonomic
severity and distribution.
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4.4.1

Study limitations

Despite the promising contributions that these data may add to our understanding of autonomic
failure, the current study contains the following limitations. 1) The current study applied a
brainstem mask that covered the whole brainstem. Certainly, there are a number of brainstem
nuclei that have different contributions to autonomic control. In the current study, we did not
focus on whether the brainstem shows increased or decreased activity, simply that there was
reduced connectivity to key cortical and subcortical sites. The authors believe the next logical
step will be to assess functional connectivity related to specific brainstem nuclei. 2) The two
proposed mechanistic models have been primarily investigated in neurodegenerative disorders
such as Alzheimer’s Disease, PD, Huntington’s disease and Amyotrophic Lateral Sclerosis. Even
though there are neurodegenerative diseases associated with autonomic failure, this work has yet
to include these patient groups. Further studies are needed to investigate these models in
autonomic failure. 3) Blood pressure data was not directly measured during the MRI session as
this often involves the invasive insertion of an arterial line. Therefore, in the current study the
heart rate change during the MRI session was compared with the heart rate changes that occurred
in the laboratory during the Valsalva maneuver. Additionally, the expiratory pressure during the
maneuver was monitored to ensure compliance. If there was a similar heart rate response, it was
assumed that the corresponding blood pressure changes in response to the maneuver were
similar. 4) The current study had a heterogeneous patient sample, including patients diagnosed
with PD plus autonomic failure. To test whether the current results were related to autonomic
failure and not PD, a sub-analysis of the patient group was performed. No significant differences
between our autonomic failure patients with and without PD were found, suggesting the current
results are related to the presence of autonomic failure and not PD pathology.

4.5

Conclusion

In the current study, patients with peripheral autonomic failure had significantly less functional
connectivity between the brainstem and key central autonomic structures both at rest and during
an autonomic maneuver. Patients showed reduced coupling between brainstem and regions of the
central autonomic network, including the cerebellum, insula, thalamus and cingulate cortices.
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These results may be attributed to two mechanistic models, including nodal stress and
transneuronal spread, which may contribute, in part, to the pathophysiology of autonomic failure.
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CHAPTER 5

5

Evidence of impaired cerebellar connectivity at rest and during autonomic
maneuvers in patients with autonomic failure4

5.1

Introduction

Neurogenic Orthostatic Hypotension (NOH) is a cardinal feature of autonomic failure. NOH
is defined as a persistent and consistent drop in systolic blood pressure ≥30 mmHg upon
standing, without an appropriate compensatory postural tachycardia1. Proper regulation of
autonomic responses is mediated through several brainstem nuclei, including the nucleus tractus
solitarius (NTS), rostral and caudal ventrolateral medulla (RVLM, CVLM, respectively),
parabrachial nucleus (PBN), etc., that serve as regulatory sites for autonomic control. These
brainstem nuclei together are part of an integrated autonomic network involved in mediating the
beat-to-beat adjustments to heart rate (HR) and blood pressure (BP). For example, during a state
of hypotension, reduced baroreceptor afferents to the NTS, result in disinhibition of premotor
sympathetic nuclei within the RVLM. Disinhibition of the RVLM, by the CVLM, results in
increased efferent signals to the intermediolateral cell column to increase efferent sympathetic
outflow with subsequent vasoconstriction and tachycardia2. NOH occurs due to failure of the
reflexive increase in efferent sympathetic outflow that would normally counteract blood pressure
changes associated with standing.
In addition to afferent inputs, efferent signals from cortical and subcortical structures also
converge at the level of the brainstem to further regulate autonomic responses3. Many studies,
incorporating different experimental modalities (i.e. electrical and chemical stimulation,
functional imaging, etc.), have uncovered a network of cortical and subcortical structures
involved in autonomic regulation. Structures such as the insular cortex, cingulate cortex,
hippocampus, prefrontal cortex, hypothalamus, thalamus and cerebellum, together with
brainstem nuclei make up key components of the central autonomic network (CAN)3–6.

4

A version of this chapter is currently under review for publication.
Baker J and Kimpinski K (2019). Evidence of impaired cerebellar connectivity at rest and during autonomic
maneuvers in patients with autonomic failure. The Cerebellum. (under review)
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Despite its consistent presence in the literature and significant contributions to cardiovascular
modulation, the cerebellum has arguably received less attention as part of the CAN, and is not
commonly recognized as a significant contributor to cardiovascular and autonomic control7.
Anatomically, autoradiography along with retrograde and anterograde tracing studies, have
revealed the structural network of neurons projecting from the cerebellum to the NTS, RVLM,
PBN and Nucleus Ambiguus8–10. Functionally, cerebellar stimulation produces significant
cardiovascular responses including increased cerebral blood flow, tachycardia and arterial
pressor responses with measurable increases in muscle, splanchnic and renal sympathetic nerve
activity11–16. Cerebellar lesions result in remarkable dysfunction in the compensatory responses
to hypotension, suggesting an essential role in cardiovascular compensation during large blood
pressure perturbations7,17,18. Finally, neuroimaging studies involving awake humans have
demonstrated cerebellar activation in response to lower-body negative pressure19 and cerebellar
and deep cerebellar nuclei activation with concomitant increased muscle sympathetic nerve
activity20.
Our laboratory recently investigated functional central network activity in patients with NOH
during standard autonomic challenges. In this study, we found that patients with NOH as a result
of autonomic failure had significantly reduced cerebellar activation in response to autonomic
challenge that perturbs heart rate and blood pressure (Valsalva maneuver and lower-body
negative pressure)21. Therefore, in the current study, we sought to determine whether NOH
patients also have impaired functional connectivity between the cerebellum and CAN structures.

5.2
5.2.1

Methods
Study participants

In total, 15 patients meeting the criteria for NOH participated in the current study (67±6 years).
All patients underwent standard tests for detecting severity and distribution of autonomic failure,
namely the Autonomic Reflex Screen22. All patients met the criteria for NOH demonstrating an
average blood pressure reduction of 80±25 mmHg with only an average compensatory
tachycardia of 9±7 bpm during Head-up Tilt. Additionally, all patients further demonstrated
evidence of adrenergic failure based on qualitative evaluation of the Valsalva maneuver, which
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revealed absent adrenergic phases (late phase II and phase IV). A Neurologist (KK) with
specialty training in autonomic dysfunction confirmed all testing and made the final diagnoses.
The composite autonomic scoring scale (CASS) was used to quantify the severity and
distribution of autonomic failure based on the ARS. The CASS provides a score across three
domains: sudomotor (0-3), cardiovagal (0-3) and adrenergic (0-4)23. On average patients scored a
2/3, 2/3 and 4/4, respectively, resulting in a total CASS of 8/10 indicative of severe and
widespread autonomic dysfunction. The patient cohort was comprised of the following
diagnoses: Pure Autonomic Failure, n=4; Parkinson’s Disease with autonomic failure, n=6;
idiopathic NOH, n=5.

Patient data were compared against fifteen healthy, age-matched controls (61±14 years; p=0.12).
Healthy participants were examined to confirm the absence of any neurological conditions
including autonomic dysfunction. Healthy participants were also excluded if they fell under any
one of the following categories: i) pregnant or lactating females, ii) clinically significant
coronary artery disease, iii) concomitant therapy with anticholinergic, alpha- and beta-adrenergic
antagonists or other medications which could interfere with autonomic functioning, and iv)
failure of other organ systems or systemic illness that could affect autonomic function or
participants’ ability to cooperate. All laboratory data were collected in the Autonomic Disorders
Laboratory at University Hospital, London, Ontario. All imaging data were collected at Robart’s
Research Institute Centre for Functional and Metabolic Imaging at The University of Western
Ontario. Ethical approval was obtained from the Health Science Research Ethics Board at
Western University, and informed consent was obtained from all participants prior to testing.

5.2.2

Neuroimaging data acquisition

All imaging data were collected using a 3T imaging system with a 32-channel head coil
(Magnetom Primsa, Siemens Medical Solutions, Erlangen, Germany). A high-resolution T1weighted structural was acquired at the beginning of the scanning session (sagittal, matrix
256x240 mm, voxel resolution 1.0x1.0x1.0 mm, 1 mm slice thickness, no gap, flip angle 9
degree, TE: 2.98 ms, TI: 900 ms, TR: 2300 ms). Blood oxygen level-dependent (BOLD) signals
were acquired using a T2- weighted gradient echo-echo planar imaging pulse sequence with the
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following parameters: TE: 30 ms; FOV: 240x240 mm; flip angle: 40 degrees; multiband
acceleration factor: 4. Forty-eight interleaved axial slices (3.0x3.0 mm in-plane voxel resolution,
TR: 1000 ms) were acquired in each volume. Following the structural scan, functional brain
imaging was performed during the following: Rest: The rest period consisted of 5 minutes of
functional scanning during which, all participants were instructed to remain still with their eyes
closed, but not to fall asleep. Lower-body negative pressure (LBNP): Following a minimum 15minute baseline, suction was applied at -35 mmHg for 5 minutes, followed by a 5-minute rest
period. All healthy participants completed LBNP at -35 mmHg. However, due to the nature of
the disease and the marked blood pressure drops in the patient group, in some cases the negative
pressure was lowered. On average, LBNP was completed at a suction pressure of -27 mmHg in
our patient group. To help minimize head movement, all participants underwent LBNP in the lab
prior to the MRI session. In addition, all participants were secured to foot plates within the box
to help with stabilization during suction. Valsalva maneuver: All participants completed three
Valsalva maneuvers. The Valsalva session was modeled as a blocked design switching between
periods of rest and the maneuver. Following a 1-min baseline, participants were instructed to
perform a Valsalva for 15-seconds, held at an expiratory pressure of 40mmHg. Real-time visual
feedback regarding the expiratory pressure was provided. Each maneuver was separated by a 2min rest in between trials. The first 10 seconds immediately following release of the maneuver
was recorded as a recovery period. The remaining 110 seconds were recorded as a rest period to
ensure hemodynamics returned to baseline. To minimize head movement each participant’s head
was placed in a cradle packed with foam padding. To minimize head movement during VM, all
participants practiced performing the VM prior to scanning while being supervised. In addition,
feedback from an MRI technician was provided if there was excessive movement, in which case
trials were repeated. Beat-to-beat heart rate was recorded from a continuous signal derived from
an MRI-compatible pulse oximeter (Nonin Medical, 8600FO MRI, Plymouth, MN) attached to
the index finger of each participant’s left hand when possible. In the presence of a significant
tremor (i.e. in PD+NOH patients), pulse oximetry was obtained from the hand with less potential
for movement. All hemodynamic recordings were collected using WR TestWorks™ software
(WR Medical Electronics Co., Stillwater, MN).
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5.2.3

Neuroimaging analysis

All imaging data were analyzed using the Conn toolbox (v18a) available through SPM12
(Wellcome Department of Imaging Neuroscience, London, UK). Preprocessing steps included
realignment, unwarping and slice-time correction. All structural and functional images were
segmented in grey matter, white matter and cerebral spinal fluid, normalized to Montreal
Neurological Institute (MNI) space and smoothed with a Gaussian kernel (Full-Width HalfMax=6 mm). To detect outlier volumes with high motion, the ART-based scrubbing method was
used (ART parameters: 2-mm subject motion threshold and a global signal threshold set at Z=9).
Nuisance variables including: 6 realignment parameters, first 5 principle components from the
white matter and CSF and the outlier volumes from the scrubbing procedure were then regressed
out of the signal. The data were linearly detrended and band-pass filtered (0.008 to 0.09 Hz).
Cerebellar functional connectivity was tested with an ROI-to-ROI approach during rest, LBNP
and VM. All areas for connectivity were defined on a regions-of-interest (ROI) basis using the
following atlases: The cerebellum was parcellated into 26 ROIs from the AAL atlas. Cortical (91
ROIs) and subcortical (15 ROIs) atlases were derived from the Harvard-Oxford Atlas.
In the first level analysis, ROI-to-ROI maps were generated for each individual during the
predefined conditions. Individual connectivity maps were created using the General Linear
Model convolved with a canonical hemodynamic response function. In the second-level analysis,
a between-subjects contrast (controls>patients [1, -1; patients>controls [-1, 1]) was performed on
the basis of a random-effects general linear model, with a seed-level correction for multiple
comparisons (false-discovery rate: p<0.05).

5.3

Results

Rest: Controls had significantly more posterior cerebellar connectivity to various key cortical
and subcortical autonomic structures, including: bilateral anterior insula, anterior cingulate
cortex, bilateral putamen and bilateral thalamus. In addition, controls had significantly more
intra-cerebellar connectivity, including connectivity between posterior cerebellum lobule 9 to:
bilateral cerebellum lobule 6, right cerebellum lobule 7, right anterior cerebellum lobule 2 and
the vermis 6. In addition, there was significant bidirectional connectivity between right
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cerebellum lobule 2 and right cerebellum lobule 6 and vermis 9 with left cerebellum lobule 9
(Figure 5.1). The effect sizes at rest were small to moderate (Table 5.1).

Valsalva maneuver (VM): During VM, controls had significantly greater functional connectivity
between structures of the central autonomic network and cerebellar seed sources. The left
anterior cerebellum (lobule 4/5) had significant connectivity with the vermis 3, brainstem,
posterior cingulate cortex and the right insular cortex and the right cerebellar lobule 4/5 (Figure
5.2A). The anterior vermis (region 4/5) showed significant connectivity with the brainstem,
while vermis region 3 was significantly connected to the right anterior parahippocampus and
PCC. Additionally, the anterior vermis (region 3) showed greater connectivity with other
cerebellar regions including: posterior vermis (region 8) and right cerebellum lobule 6 and
bilateral cerebellar lobule 4/5. (Figure 5.2B). Finally, the posterior cerebellum (lobule 6) had
significantly greater connectivity to the brainstem and right hippocampus, and the bilateral
posterior cerebellum (lobule 9) was significantly connected to the brainstem (Figure 5.2C). The
effect sizes for the connectivities during VM were moderate to strong (Table 5.2).

LBNP: In response to an orthostatic challenge, controls showed significantly greater connectivity
between the left posterior cerebellum (lobule 9) and the bilateral thalamus as well as the right
posterior cerebellum (lobule 9) and the bilateral thalamus and left putamen (Figure 5.3). The
effect sizes for the connectivity during LBNP were modest (Table 5.3).
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Table 5.1 Regions of greater cerebellar connectivity at rest in healthy controls versus NOH
patients.
Side
Effect Size
T-value
p-FDR value
Anterior Cerebellum
(R) Cerebellum Lobule 2 R
0.34
3.91
0.03
Cerebellum Lobule 6
Posterior Cerebellum
(R) Cerebellum Lobule 6 Cerebellum Lobule 2
Vermis Lobule 6 –
Cerebellum Lobule 9
(L) Cerebellum Lobule 9 Vermis Lobule 6
Cerebellum Lobule 7
Thalamus
Putamen
Thalamus
Cerebellum Lobule 6
Cerebellum Lobule 2
Anterior Insula
Cerebellum Lobule 6
(R) Cerebellum Lobule 9 Anterior Insula
Anterior Insula
Thalamus
Putamen
Putamen
Thalamus
Anterior Cingulate Cortex
Vermis Lobule 6
Abbreviations: R, right; L, left

R

0.34

3.91

0.03

L

0.31

3.80

0.04

R
L
L
R
R
R
R
L

0.31
0.23
0.33
0.28
0.28
0.23
0.25
0.26
0.23

3.80
3.17
3.15
3.03
2.92
2.92
2.89
2.82
2.79

<0.05
<0.05
<0.05
<0.05
<0.05
<0.05
<0.05
<0.05
<0.05

0.34
0.31
0.38
0.30
0.32
0.35
0.29
0.24

4.84
4.51
4.51
4.34
4.26
3.95
3.41
2.86

<0.005
<0.005
<0.005
<0.005
<0.005
<0.005
<0.05
<0.05

R
L
L
L
R
R
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Table 5.2 Regions of greater cerebellar connectivity in healthy controls versus NOH patients
during Valsalva maneuver.
Side
Effect Size
T-value
p-FDR value
Anterior Cerebellum
Vermis Lobule 4/5 - Brainstem
0.76
4.31
0.02
(L) Cerebellum Lobule 4/5 to:
Vermis Lobule 3
Insula
Brainstem
Posterior cingulate cortex
Cerebellum Lobule 4/5
Vermis Lobule 3 to:
Anterior Para-hippocampus
Cerebellum Lobule 4/5
Posterior cingulate cortex
Cerebellum Lobule 4/5
Vermis Lobule 8
Cerebellum Lobule 6
Posterior Cerebellum
(L) Cerebellum Lobule 6 to:
Brainstem
Hippocampus
(L) Cerebellum Lobule 9 Brainstem
(R) Cerebellum Lobule 9 Brainstem
Abbreviations: R, right; L, left

0.79
0.76
0.82
0.65
0.56

4.39
4.21
3.97
3.76
3.59

0.012
0.012
0.014
0.017
0.00

R

0.53
0.79
0.61
0.63
0.58
0.57

4.63
4.39
4.18
3.88
3.29
3.28

0.008
0.008
0.009
0.013
0.03
0.03

R

0.9
0.6

4.82
3.87

0.006
0.03

0.74

4.53

0.012

0.75

5.29

0.002

R

R

R
L
R
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Table 5.3 Greater posterior cerebellar connectivity in healthy controls versus NOH patients
during lower-body negative pressure.
Side
Effect Size
T-value
p-FDR value
Posterior Cerebellum
(L) Cerebellum Lobule 9 to:
Thalamus
L
0.34
4.1
0.02
Thalamus
R
0.32
3.76
0.02
(R) Cerebellum Lobule 9 to:
Putamen
Thalamus
Thalamus
Abbreviations: R, right; L, left

L
L
R

0.3
0.3
0.28

4.17
3.44
3.43

0.02
0.04
0.04
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Figure 5.1. Cerebellar connectome at rest [Controls>Patients].
At rest, controls showed significantly greater intra-cerebellar connectivity, and greater
cerebellar connectivity to the bilateral insula, bilateral putamen, bilateral thalamus and anterior
cingulate cortex (ACC). Strength of connectivity is represented across a colour spectrum with
red representing larger T-values and stronger connectivity.
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A

B

C

Figure 5.2 Cerebellar connectome during Valsalva maneuver [Controls>Patients].
Anterior (A), Vermis (B) and Posterior (C) cerebellar connectome during Valsalva maneuver [Controls>Patients]. Controls had
significantly greater intra-cerebellar, cerebellum-cortical and cerebellar-brainstem connectivity during the Valsalva maneuver
compared to NOH patients. Strength of connectivity is represented across a colour spectrum with red representing larger T-values and
stronger connectivity.
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Figure 5.3. Cerebellar connectome during lower-body negative pressure [Controls>Patients].
Controls showed significantly greater connectivity between the posterior cerebellum lobule 9
and the thalamus and putamen during lower-body negative pressure. Strength of connectivity
is represented across a colour spectrum with red representing larger T-values and stronger
connectivity.
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5.4

Discussion

Previously, we found that patients with NOH had significantly reduced cerebellar activation in
response to autonomic challenges21. In the current study, we explored these findings further by
assessing cerebellar functional connectivity and found the following three findings: 1. Patients
had significantly less functional connectivity in cerebellar regions that have been highly
implicated in cardiovascular autonomic control. 2. Patients had significantly less connectivity
between cerebellar regions and the brainstem. 3. Patients had significantly less functional
connectivity between the cerebellum and other structures of the central autonomic network.
Patients with NOH experience a significant drop in blood pressure related to upright posture.
This occurs due to a failure of the autonomic nervous system to reflexively increase sympathetic
nerve activity. The cerebellum is involved in the integration of vestibular information regarding
postural changes to facilitate an early compensatory increase in sympathetic nerve activity via
the brainstem to help maintain blood pressure upon standing. In the current study patients
showed significantly less connectivity between the cerebellum, including the vermis and lobule
9, and the brainstem. Structural and functional experimental data in animal and human subjects
support two major pathways between the cerebellum and brainstem through which
cardiovascular autonomic reflexes are regulated. The first operates through the vestibular nucleus
complex (VNC) to mediate the vestibulosympathetic reflex (VSR)24,25 and the second through
the baroreflex arc11. These pathways converge on several brainstem autonomic nuclei, including
at the level of the RVLM. Moreover, the fastigial nucleus (FN), vermis and lobule 9 of the
posterior cerebellum are key cerebellar structures involved in both pathways. Together, these
structures form a cerebellar-brainstem network for cardiovascular autonomic control that may be
impaired in patients with NOH.

5.4.1

Cerebellum and the baroreflex

Anatomically, regions of the cerebellum project to important brainstem nuclei involved in
baroreflex control, including the NTS, PBN and RVLM9,11,15. Functionally, rostral FN
stimulation results in a pronounced increase in renal sympathetic nerve activity, vasoconstriction
and concomitant pressor responses in several species12–14,16. Following sympathectomy/Alpha
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blocker, this pressor response is abolished, suggesting the response pathway is sympatheticallymediated26,27. Further evidence to support the FN in baroreflex control was provided by Lisander
and Martner who demonstrated that FN stimulation produced similar BP, HR and blood flow
patterns to that caused by carotid baroreceptor unloading26. Furthermore, studies reveal altered
baroreflex, decreased heart rate and redistribution of cardiac output following cerebellar
lesions/cerebellectomies28,29. The anterior vermis (AV) also has direct projections to the PBN
and studies have shown that PBN stimulation also activates the anterior vermis, suggesting a
vermis-PBN complex30. Functionally, AV stimulation inhibits sympathetic nerve activity,
subsequently producing a depressor effect. In addition, when the AV is stimulated prior to FN
stimulation, it effectively depresses the pressor response normally elicited by FN stimulation,
suggesting an inhibitory/modulatory role of the AV11. Overall, the AV may mediate sympathoinhibition that, together with the FN, provides a regulatory micro-complex for cardiovascular and
baroreflex control. Finally, stimulation of lobule 9 of the posterior cerebellum induces a large
increase in renal sympathetic nerve activity, with an accompanying tachycardia and pressor
response. This response can be effectively abolished following sympathetic ganglion blockade,
suggesting it too is sympathetically-mediated11. Furthermore, Paton and colleagues found that
when arterial baroreceptors were activated with concomitant lobule 9 stimulation, the subsequent
reflexive changes in HR and BP associated with baroreceptor activation failed to occur. The
authors found that lobule 9 stimulation effectively decreased or abolished the activity of barosensitive neurons within the NTS, suggesting the posterior cerebellum facilitates changes in HR
and BP by inhibiting baroreceptor input at the level of the NTS31.

5.4.2

Vestibulo-sympathetic reflex

In addition to baroreflex nuclei, vestibular nuclei within the brainstem also contribute to proper
cardiovascular autonomic regulation. Considerable experimental evidence shows an important
role of the vestibular system in regulating sympathetic nerve activity. Together, the integration of
vestibular information to generate a sympathetic response forms the physiological basis for the
vestibulo-sympathetic reflex (VSR). Evidence has accumulated, which has conclusively
demonstrated the contribution of the cerebellum and the vestibular system to facilitate an early
burst in sympathetic nerve activity to help maintain postural control of blood pressure.
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The vestibular nucleus complex (VNC) is located on either side of the brainstem in the region of
the pons and medulla, and is comprised of four nuclei: the superior, inferior, medial and lateral.
Each nucleus has projections to autonomic regulatory nuclei in the brainstem, including the
RVLM, CVLM and NTS24,32. Similar to the baroreflex, the RVLM serves as the primary
premotor region for mediating the sympathetic response association with the VSR. Studies to
support this have shown that neurons of the RVLM not only respond to vestibular nerve
stimulation25,33, but also that the VSR is abolished following lesions to the RVLM. Furthermore,
Kerman and Yates (1998) demonstrated that stimulation of the baroreceptors via a pressor
response resulted in an attenuation of the VSR34. As both vestibular and baroreceptor inputs
converge at the level of the RVLM, this may highlight a major site for modulation. The VNC
also receive a wide array of input signals from the cerebellum and higher-order brain structures,
thus making the VNC a prime candidate for information integration to facilitate autonomic
responses.
The cerebellum projects heavily to the VNC, which, as previously discussed, sends direct inputs
to the NTS, RVLM and CVLM. Together, these structures form a cerebellar vestibulosympathetic complex capable of integrating vestibular and cardiovascular signals to regulate
autonomic responses. Similar to the cerebellum-baroreflex pathway, the cerebellar inputs to the
vestibular nuclei are largely mediated through extensive projections from the fastigial nucleus
and lobule 9 of the posterior cerebellum. A number of studies have demonstrated extensive
bilateral projections between the FN and the VNC11,24,32. These fastigio-vestibular fibers appear
to have excitatory actions, which may provide an additional framework for the VSR. Moreover,
lobule 9 projections to the VNC have also been well described in a number of species.
Specifically, projections from the lateral nodulus-uvula were observed to terminate in the lateral,
superior and medial vestibular nuclei along with the PBN11. Purkinje cells in the uvula of lobule
9 provide monosynaptic input to the superior and medial VN, which mediated the VSR, and
disynaptic inputs to the NTS24. Thus, lobule 9 of the posterior cerebellum appears to have the
anatomical framework to support a role in regulating both the VSR and baroreflex.
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5.4.3

Cerebellar-cerebral connectivity:

Finally, in the current study, patients with NOH had significantly less functional connectivity
between the cerebellum and a number of higher-order structures including the insula, cingulate
cortices, thalamus and hippocampus. Structures of the CAN including those previously
mentioned, have been highly implicated in autonomic control. For example, the insula projects
directly to a number of cortical and subcortical sites known to facilitate autonomic responses
such as the hypothalamus, PBN and NTS 35–37. However, studies have also shown direct corticovestibular projections suggesting an additional pathway for cortical autonomic regulation,
through the VNC. In cats, retrograde tracers in the vestibular nuclei show widespread cerebral
labeling38, while studies involving non-human primates have demonstrated direct projection
from a number of higher cortical structures to vestibular nuclei, including the insula and anterior
cingulate cortex39.
As most postural changes are the result of voluntary, and as such, planned and executed
movements, it seems appropriate that higher brain structures would be involved to proactively
regulate brainstem neurons to increase sympathetic activity. This idea of a “central command”
network to facilitate autonomic responses is not new and is conclusively supported. For example,
individuals who are paralyzed can elicit graded heart rate and blood pressure responses to
imagined exercise40. Central command also contributes to adjustments to baroreflex gain and it
has been suggested that higher brain regions may also adjust VSR gain, such that the response is
appropriate for the ensuing postural change24. However, more work is needed to better
understand where (i.e. VNC, RVLM, CVLM, NTS) the adjustment occurs.

5.5

Conclusion

Overall, the combination of anatomical and functional studies in animal and humans substantiate
a significant role for the cerebellum in cardiovascular autonomic control. Specifically, a number
of CAN structures including the cerebellum, brainstem and higher cortical structures form a
complex network capable of integrating vestibular and cardiovascular information to facilitate
appropriate autonomic adjustments during postural changes. In the current study, patients with
neurogenic orthostatic hypotension show evidence of reduced cerebellar-brainstem and
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cerebellar-cortical connectivity. Evidence of impaired cerebellar connectivity may contribute to
the inability to properly regulate blood pressure during postural changes and perhaps provide
further understanding of the pathophysiology of NOH.
Acknowledgements: This work was partly funded by the Canada First Research Excellence
Fund to BrainsCAN. The authors would also like to thank Scott Charlton for his excellent
technical services during MRI data collection.
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CHAPTER 6

6

Initial validation of symptom scores derived from the Orthostatic Discriminant and
Severity Scale5

6.1

Introduction

Orthostatic symptoms occur when one changes position from lying or sitting to standing.
Orthostatic Intolerance (OI) is associated with numerous forms of autonomic dysfunction,
ranging from severe autonomic disorders (i.e. Pure Autonomic Failure, Multiple System
Atrophy, Neurogenic Orthostatic Hypotension) to milder syndromes (i.e. Postural Tachycardia
Syndrome, Syncope, Orthostatic Intolerance)1–4. Symptoms associated with OI such as
lightheadedness, dizziness, faintness and heart palpitation leading to possible syncope5 are the
primary cause of morbidity in patients with dysautonomia. Additionally, these symptoms are
often worsened by specific stressors including, but not limited to, exertion, high ambient
temperatures, hot showers and baths, consumption of large meals and prolonged standing,
making orthostatic symptoms particularly disabling and burdensome to activities of daily living3.
However, due to the non-specific nature of orthostatic symptoms, such as lightheadedness and
dizziness, other more common etiologies are often considered prior to OI and autonomic
dysfunction. To add to this problem, OI can also have numerous accompanying constitutional
symptoms such as: fatigue, generalized weakness and shoulder and neck pain6. In such cases,
clinicians may focus on these symptoms, without associating them with OI. Therefore, accurate
identification and distinction between orthostatic versus non-orthostatic symptomatology is
important for accurate diagnoses and treatment management.

5

A version of this chapter has been published. Used with permission from Springer Nature
Baker J, Paturel J, Sletten DM, Low PA and Kimpinski K (2019). Initial validation of symptom scores derived from
the orthostatic discriminant and severity scale. Clin Auton Res. 29(1): 105-112.
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Currently, there is no simple instrument, easily accessible to clinicians to help make this
distinction and to discriminate symptoms as being orthostatic or non-orthostatic. Current
validated questionnaires focused on orthostatic symptoms include: 1. Autonomic Symptom
Profile (ASP), and 2. Orthostatic Hypotension Question (OHQ). The ASP is a comprehensive
questionnaire (169 questions) with a focus on all aspects of autonomic dysfunction, with OI
being a small portion of this assessment7. In contrast, the OHQ is short and the calculated results
are easily obtainable and restricted to the assessment of the severity of orthostatic symptoms and
the effects on daily living. However, the OHQ focuses on symptoms related to low blood
pressure problems as opposed to generalized OI8. While these instruments provide important
information on orthostatic symptoms, they do not address how orthostatic symptoms are
differentiated from non-orthostatic symptoms.
Therefore, we developed the Orthostatic Discriminant and Severity Scale (ODSS) to help
discriminate symptoms as being either orthostatic or non-orthostatic in nature. The ODSS is a
short, 33-question, self-report questionnaire that provides an orthostatic score and non-orthostatic
score. The ODSS implements clinical questions routinely used in practice by clinicians to
identify symptoms as being either orthostatic or non-orthostatic. The objectives of the current
study were to analyze the orthostatic scores and non- orthostatic symptom scores derived from
the ODSS with respect to: 1. Convergent validity, 2. Clinical validity and 3. Test-retest
reliability.

6.2
6.2.1

Methods
Study participants

This was a prospective study evaluating validity and reliability of the ODSS in persons with
orthostatic intolerance against asymptomatic healthy controls. Patients were recruited from the
Autonomic Disorder Laboratory within the Department of Clinical Neurological Sciences,
University Hospital, London, Canada. All patients were seen by a neurologist to confirm the
presence of orthostatic intolerance. In addition, all healthy participants were examined to confirm
the absence of any neurological condition including autonomic dysfunction and symptoms
related to OI. In addition, healthy participants were excluded if they fell under any one of the
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following categories: i) pregnant or lactating females, ii) clinically significant coronary artery
disease, iii) concomitant therapy with anticholinergic, alpha- and beta-adrenergic antagonists or
other medications which could interfere with autonomic functioning, and iv) failure of other
organ systems or systemic illness that could affect autonomic function or participants’ ability to
cooperate. All study participants completed the Autonomic Reflex Screen (ARS) and 3 selfreport questionnaires (Autonomic Symptom Profile, Orthostatic Hypotension Questionnaire,
Orthostatic Discriminant and Severity Scale). Study participants were asked to repeat the ODSS
two weeks later to calculate test-retest reliability. Ethical approval for this study was obtained
from the Health Sciences Research Ethics Board at Western University and written informed
consent was obtained from each participant prior to study commencement.

6.2.2
6.2.2.1

Clinical Evaluation
Autonomic reflex screen

Standardized autonomic testing was performed as previously described9,10. In brief, Quantitative
Sudomotor Axon Reflex Test (QSART) was used to evaluate post-ganglionic sympathetic axon
integrity using a QSWEAT device (WR Medical Electronics Co., Stillwater, MN) and multicompartmental sweat capsules. Adrenergic function was assessed using beat-to-beat blood
pressure and heart rate responses to Valsalva maneuver (VM) and Head-up Tilt (HUT).
Cardiovagal function was assessed using heart rate response to deep breathing (HRDB) and
Valsalva ratio (VR) calculated from the VM. Heart rate and blood pressure were continuously
recorded using an electrocardiograph (ECG) (Model 3000 Cardiac Trigger Monitor, IVY
Biomedical Systems, Inc., Branford, CT) and Nexfin hemodynamic monitoring system (BMEYE
Cardiovascular, Amsterdam, Netherlands), respectively. All data were recorded and analyzed
using WR Testworks™ software. The composite autonomic scoring scale (CASS) was derived
from the ARS as previously described11. The CASS provides a quantitative measure of the
severity and distribution of autonomic dysfunction. The 10-point CASS is divided into the
following 3 indices: Cardiovagal Index (0-3), Adrenergic Index (0-4) and Sudomotor Index (03). Qualitative assessment of the adrenergic phases associated with the Valsalva maneuver (late
phase II and phase IV) were used when providing an adrenergic score. A score of 1-3 is
indicative of mild autonomic dysfunction, 4-6 as moderate, and 7-10 as severe autonomic
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dysfunction. An additional score of 0 was used to indicate no autonomic dysfunction. Therefore,
in the context of the current study with the use of healthy control participants, an 11-point CASS
was used (0-10).

6.2.2.2

Questionnaires

Orthostatic Discriminant and Severity Scale (ODSS): The ODSS was developed by clinicians
experienced in autonomic dysfunction and specific orthostatic disorders, an epidemiologist with
experience in questionnaire development and administration, by reviewing other validated
questionnaires, and by extensive interactions with patients with orthostatic intolerance to identify
symptom commonalities. The ODSS is a self-report questionnaire comprised of 33 questions.
The questions are used routinely in practice to identify orthostatic intolerance, and include
symptom frequency, severity, duration and recovery in addition to specific orthostatic stressors
such as, prolonged standing, meal consumption and heat stress. Non-orthostatic symptoms were
comprised of questions related to constitutional symptoms including, generalized weakness,
fatigue and pain. In addition, symptoms of lightheadedness and dizziness unrelated to upright
posture and unrelated to a change in position were included. The questions are preceded by
instructions to rate each item by selecting the response that best described the symptoms one
experiences on an average basis. The recall period was over the past year. This timeframe was
chosen to ensure: 1. Symptoms were persistent and consistent, 2. Patients had sufficient time to
experience a variety of circumstances in which their symptoms could have been affected (i.e. hot
weather), 3. Symptoms that have since passed and are no longer present were not being recorded.
The primary items were scored on a dichotomous scale as either “yes” or “no” questions
followed by conditional questions pertaining to frequency, severity, duration, and symptom
recovery. Conditional questions were used to save time for patients with few or no symptoms.
Access to the questionnaire can be found in the appendix and at:
https://www.surveymonkey.com/r/guestODSS
Scoring: The ODSS provides an Orthostatic Symptoms Score and a Non-Orthostatic Symptoms
Score”. The Orthostatic symptoms score is calculated as the sum of 22 questions related to
orthostatic intolerance, while the non-orthostatic symptoms score is calculated as the sum of 11
questions pertaining to more generalized symptoms. There were ten conditional questions

109

requiring a ‘yes’ or ‘no’ response. Conditional questions were given a weighted value of either 0
or 1. Questions indicative of orthostatic intolerance were given a value of 1, whereas generalized
symptoms and symptoms unrelated to the upright position were given a value of 0. The
following is a sample question indicative of orthostatic intolerance: “In the past year, have you
experienced symptoms of faintness, dizziness, and/or lightheadedness soon after standing up
from a sitting or lying position?” A positive response would be given a value of 1, whereas a
negative response would receive a value of 0. In the event of a positive response, follow-up
questions would ensue. Follow-up questions were assessed using a 7-point Likert scale. A 7point Likert scale was chosen to offer more points of discrimination. Answers indicative of
orthostatic intolerance were weighted more heavily. The following is an example of a follow-up
question in the event the previous question had a positive response: “Please rate the amount of
relief of your symptoms of faintness, dizziness and/or lightheadedness upon lying/sitting back
down”. A response of ‘No relief at all’ would receive a weighted score of 0, whereas ‘Complete
relief’ would receive a weighted score of 6. Similarly, if the answer for a conditional question for
non-orthostatic symptoms is "No", this would warrant a score of 1, as higher scores are
indicative of orthostatic intolerance. The lowest attainable Orthostatic and Non-Orthostatic
scores are both a score of 0. The highest attainable Orthostatic symptoms score is 87 and 61 for a
Non-Orthostatic symptoms score. In addition to the ODSS, all participants completed two other
previously validated questionnaires. Additional questionnaire assessment included: the
Autonomic Symptom Profile (ASP) 7 and the Orthostatic Hypotension Questionnaire (OHQ)8. A
composite OHQ score was generated by averaging the orthostatic hypotension symptoms
assessment (OHSA) and orthostatic hypotension daily activity scale (OHDAS).

6.2.3

Statistical analysis

Descriptive statistics are presented as mean ± standard deviation. All measures among persons
with and without orthostatic intolerance were compared using an independent t-test. Statistical
correlations were performed using Spearman’s correlation coefficient. An alpha level of 0.05
was used to denote significance. All statistical analyses were performed using SPSS® statistical
software version 21 for Windows (SPSS, Inc., Chicago, IL).
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6.2.3.1

Validity

Convergent validity was assessed by correlating the results of the ODSS with the Orthostatic
Index of the ASP and the average OHDAS and OHSA scores calculated from the OHQ. Clinical
validity was evaluated by assessing the relationship between the ODSS and a clinically validated
orthostatic challenge (Head-up Tilt test), and the total CASS derived from all components of the
ARS.

6.2.3.2

Reliability

Test-retest reliability was calculated using a Model 3 (two-way mixed, consistency) single
measure intra-class correlation coefficient between week 1 and week 2 ODSS scores. Cronbach’s
alpha was determined as a measure of internal consistency for both the orthostatic and nonorthostatic symptoms scores. All items were included in the calculation of internal consistency.

6.3
6.3.1

Results
Participants

A total of 77 persons without orthostatic intolerance (age: 54±20 years) and 67 participants with
confirmed orthostatic intolerance (47 Neurogenic Orthostatic Hypotension (NOH); 12 Postural
Tachycardia Syndrome (POTS); 8 syncope) (age: 57±19 years) (p=0.45) completed the study.
All diagnoses were confirmed by a Neurologist trained in autonomic dysfunction (KK). NOH
was clinically defined as a sustained reduction in systolic blood pressure ≥30 mmHg within 3
minutes of head-up tilt (HUT) without an appropriate compensatory tachycardia 5. The NOH
cohort consisted of idiopathic NOH (n=21), Parkinson’s Disease +NOH (n=12), Diabetic
autonomic neuropathy (n=7), multiple system atrophy (n=4), pure autonomic failure (n=1) and
autoimmune autonomic ganglionopathy (n=2). POTS was clinically defined by a heart rate
increment ≥30 beats/minute within 5 minutes of HUT in the absence of orthostatic hypotension,
along with orthostatic symptoms5,12,13. Syncope was defined as a transient loss of consciousness
preceded by prodromal symptoms including, but not limited to, pallor, diaphoresis, nausea,
lightheadedness, dizziness, weakness, visual disturbances etc. 14. Table 6.1 shows the results
obtained from the autonomic reflex screen. Persons with orthostatic intolerance had reduced
sweat volumes at the proximal leg, distal leg and foot relative to the persons without orthostatic
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intolerance. Cardiovagal tests (HRDB and VR) were also significantly lower in persons with
orthostatic intolerance (p<0.001). Resting HR and SBP were significantly higher in the
orthostatic group (p<0.001). Meanwhile, the absolute drop in SBP on head-up tilt was
significantly larger (p<0.001), with a non-significant peak compensatory tachycardia (p<0.06).
In response to Valsalva, all patients with NOH had absent adrenergic phases, which contributed
to a higher adrenergic index associated with the Composite autonomic scoring scale (CASS).
Lastly, the total CASS was significantly higher in the orthostatic group (4.4±3.5) versus the nonorthostatic group (0.37±0.83; p<0.001).

6.3.2

Questionnaires

Non-orthostatic participants had significantly lower OHDAS (0.07±0.26; p<0.001) and OHSA
(0.20±0.54; p<0.001) scores calculated from the OHQ, resulting in a significantly lower
composite OHQ score (0.14±0.31) and significantly lower Orthostatic Indices derived from the
ASP (4.0±5.8) compared to participants with orthostatic intolerance (OHDAS: 4.87±3.05;
OHSA: 4.63±2.77; Composite OHQ: 4.75±2.70; ASP: 28.25±8.8; p<0.001). Convergent
Validity: Orthostatic (OS) and Non-orthostatic (NS) scores were significantly correlated with the
Orthostatic Index derived from the ASP (OS: r=0.903; NS: r=0.651; p<0.001) (Figure 6.1A), and
the Composite Score of the OHQ: (OS: r=0.800; NS: r=0.574; p<0.001) (Figure 6.1B). Clinical
Validity: Persons with orthostatic intolerance obtained significantly higher orthostatic scores
compared to study participants without orthostatic intolerance (66.5±18.1 vs. 17.4±12.9,
respectively; p<0.001) (Figure 6.2A). Additionally, persons with orthostatic intolerance scored
higher on the non-orthostatic symptom score compared to non-orthostatic participants (19.9±11.3
vs. 10.2±6.8, respectively; p<0.001) (Figure 6.2A). Orthostatic and non-orthostatic scores were
significantly correlated with the total CASS score derived from the Autonomic Reflex Screen
(OS: r=0.458; NS: r=0.315; p<0.001), and both had a significant negative correlation with the
drop in systolic blood pressure on head-up tilt (OS: r=-0.445; NS: r=-0.354; p<0.001) (Figure
6.2B). Test-retest reliability: Test-retest reliability for orthostatic scores was strong (r=0.96;
p<0.001), with an internal consistency of 0.98. The test-retest reliability for non-orthostatic
scores was moderate (r=0.57; p<0.001) with an internal consistency of 0.73. On average, the
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non-orthostatic study cohort completed the second ODSS 18±6 days later, and the orthostatic
cohort 19±6 days later (p=0.65).

Table 6.1 Autonomic reflex screen in persons with and without orthostatic intolerance
Orthostatic
Non-Orthostatic
Intolerance
Intolerance
QSART (µL±SD)
Mean ± SD
Mean ± SD
p-value
Forearm
0.90±0.90
1.09±1.10
=0.30
Proximal Leg
0.69±0.91
1.18±1.20*
=0.01
Distal Leg
0.51±0.55
1.17±1.31*
<0.001
Foot
0.54±0.48
0.99±0.88*
=0.02
Deep Breathing (bpm)
10.3±11.7
17.±9.4*
<0.001
Valsalva Ratio
1.5±0.5
1.9±0.4*
<0.001
Head-Up Tilt
Resting HR (bpm)
72.7±11.9
63.9±11.8*
<0.001
ΔHR (bpm)
18.5±15.7
23.0±11.7
=0.06
Resting SBP (mmHg)
146.2±29.3
126.7±19.9*
<0.001
ΔSBP (mmHg)
-61.9±36.5
-20.1±10.5*
<0.001
a
Abbreviations: QSART, quantitative sudomotor axon reflex test; HR, heart rate; SBP,
systolic blood pressure; Δ change from rest * - indicated significantly different values
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A

B

Figure 6.1 Convergent validity
Correlations between Orthostatic (OS) (solid line) and Non-Orthostatic (NS) (hashed line) Symptom
scores derived from the Orthostatic Discriminant and Severity Scale and previously validated tools
demonstrate strong convergent validity. A. Symptom Scores were significantly correlated with the
Orthostatic Index of the Autonomic Symptom Profile (OS: r=0.903; NS: r=0.651; p<0.001). B. Symptom
Scores were significantly correlated with the composite score of the Orthostatic Hypotension
Questionnaire (OHQ) (OS: r=0.800; NS: r=0.574; p<0.001).
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A

B

Figure 6.2 Clinical validity
A. Persons with orthostatic intolerance demonstrate significantly larger Orthostatic and Non-Orthostatic
Symptom Scores compared to persons without orthostatic intolerance (*p<0.001). B. Orthostatic (r=-0.445;
p<0.001) (solid line) and Non-Orthostatic (r=-0.354; p<0.001) (hashed line) Symptom Scores demonstrate a
significant negative correlation with the change in systolic blood pressure in response to Head-up Tilt of the
autonomic reflex screen.
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6.4

Discussion

The objective of the present study was to demonstrate preliminary validity and reliability of the
Orthostatic and Non-Orthostatic Symptom Scores derived from the Orthostatic Discriminant and
Severity Score (ODSS). Our results reveal three major findings. First, the Orthostatic and NonOrthostatic Symptom Scores demonstrated strong convergent validity as evidenced by the strong
positive correlations with previously validated tools (ASP and OHQ). Second, the Orthostatic
and Non-Orthostatic Symptom Scores demonstrate strong clinical validity as evidenced by: i)
significant correlations with the blood pressure drop in response to an orthostatic challenge
(Head-up Tilt), ii) significant correlations with the total CASS derived from tests of the ARS
which are reproducible and standardized11, and iii) patients diagnosed orthostatic intolerance
produced significantly higher Orthostatic and Non-Orthostatic Symptom Scores compared to
participants without orthostatic intolerance. Third, both Orthostatic and Non-Orthostatic
Symptom Scores were reproducible as indicated by strong test-retest reliabilities.
Orthostatic Intolerance (OI) can produce a wide array of symptoms including lightheadedness,
dizziness, and faintness. OI is important to detect because 1) it may be associated with increased
morbidity, mortality, and more progressive forms of autonomic dysfunction, 2) symptoms can be
improved with treatment, 3) it may reduce unnecessary tests and treatments that could further
complicate a patient’s orthostatic symptoms. The overall aim of the ODSS is that it will be able
to address all of these important issues related to orthostatic intolerance associated with
autonomic dysfunction.
The presence of OI can be indicative of more serious and progressive forms of autonomic
dysfunction. Included in this group are patients with neurogenic orthostatic hypotension (NOH),
pure autonomic failure, multiple system atrophy, autoimmune autonomic ganglionopathy,
general neuropathies and Lewy body disorders. Typically, patients are referred to specialists for
treatment and management of these diseases. However, it is not unusual for patients to
experience symptoms for years prior to accurate identification of such symptoms as being related
to a disorder involving orthostatic/autonomic dysfunction. Therefore, earlier symptoms
assessment could lead to earlier diagnosis, more focused tests and specialized treatments.
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Orthostatic symptoms can also produce non-specific symptoms such as headache, muscle and
non-specific neck pain, fatigue or generalized weakness6,15. In such cases, patients’ complaints
may be dismissed due to the non-specific nature of the symptoms, or they can misguide
clinicians in making a proper diagnosis. More common syndromes and disorders related to
lightheadedness and dizziness, such as inner ear/vestibular issues, benign positional vertigo,
migraines, hypoglycemia, anemia and even certain medications may be considered prior to
autonomic dysfunction. Therefore, early and accurate identification of OI can reduce the need for
unnecessary tests and avoid the use of incorrect treatments that could further complicate
symptoms. For example, NOH is a form of OI characterized by a drop in systolic blood pressure
≥30mmHg upon standing5. However, approximately 50% of NOH patients have associated
supine hypertension16. Traditional use of anti-hypertensives to treat hypertension greatly
exacerbates the blood pressure drop upon standing, which in turn exacerbates the level of OI
experienced by these patients and increases the potential for falls and more acute adverse events.
Therefore, proper identification of OI helps reduce unnecessary testing and helps to focus
treatment approaches
The overall aim of the ODSS is not only to identify and quantify orthostatic symptoms, but to
discriminate true orthostatic intolerance from other syndromes and disorders that may present
with similar symptomatology. However, prior to evaluating the ability of the ODSS in making
this distinction, assessment of initial validity and reliability of the symptom score was necessary.
In the current study, we demonstrated preliminary evidence that the ODSS is capable of
producing scores that are both valid and reliable.

6.4.1

Study limitations

The ODSS has demonstrated preliminary evidence that it provides scores of orthostatic and nonorthostatic symptoms that are both valid and reliable. Furthermore, the ODSS is capable of
accurately identifying orthostatic symptoms in patients with OI. In addition, studies including
other clinical populations are ongoing with the aim of demonstrating its ability to discriminate
between orthostatic and non-orthostatic symptomatology. Despite the promising results, the
current study contains the following limitations: 1) The current study aimed to validate the
symptom scores of the ODSS in a group of patients with known orthostatic intolerance, and 2)
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the sensitivity and specificity were not assessed. To address these limitations, the next steps are
to continue with recruitment of patients with and without orthostatic intolerance prior to any
autonomic testing. This aspect of the study will be done in a single-blinded fashion with the
researchers blinded to the results of the autonomic testing and final clinical diagnoses. In
addition, we aim to describe the severity of orthostatic intolerance based on the calculated
orthostatic and non-orthostatic scores. Following completion of the second part of the study, we
plan to make the ODSS publicly available so clinicians have easy and global access to the scale.

6.5

Conclusions

The current study demonstrates the ability of the Orthostatic Discriminant and Severity Scale to
produce Orthostatic and Non-Orthostatic Symptom Scores that are both valid and reliable.
Orthostatic and Non-Orthostatic Symptom Scores were significantly larger in persons with
orthostatic intolerance versus persons without, these scores demonstrated strong correlations
with existing instruments, and were significantly correlated with the results of standard clinical
autonomic testing, including an orthostatic challenge.
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CHAPTER 7

7

The Orthostatic Discriminant and Severity Scale (ODSS) – an assessment of
orthostatic intolerance6

7.1

Introduction

Accurate identification and distinction between orthostatic (postural) versus non-orthostatic
(non-postural) symptomatology is important for accurate diagnoses and treatment management
for disorders of the autonomic nervous system. To help make the distinction and to discriminate
symptoms as being either orthostatic or non-orthostatic, we developed the Orthostatic
Discriminant and Severity Scale (ODSS). Previously, we presented initial validation and
reliability of the symptom scores derived from the ODSS7. These previous data showed that the
ODSS produced orthostatic and non-orthostatic symptom scores that are highly correlated with
previously validated tools for assessing autonomic dysfunction and symptom severity, as well
correlated highly with standard tests of autonomic function. In the current study, our objective
was to evaluate specificity, sensitivity and inter-item reliability of the symptom scores derived
from the ODSS. Additionally, we aimed to assess predictive power of the symptom scores in a
group of patients referred for queries of autonomic dysfunction.

6

A version of this chapter has been published. Used with permission from Springer Nature
Baker J, Paturel J, Sletten DM, Low PA and Kimpinski K (2019). The Orthostatic Discriminant and Severity Scale
(ODSS): an assessment of orthostatic intolerance. Clin Auton Res. [Epub ahead of print]
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7.2
7.2.1

Methods
Participants

All healthy participants were recruited from the general population via poster and newspaper
advertisements, as well as in person from activity centers for aging populations, to ensure a
representative sample size that would age-match with the older patient cohort (i.e. Parkinson’s +
NOH; Pure Autonomic Failure, etc.). All healthy participants were examined to confirm the
absence of any neurological conditions including autonomic dysfunction and symptoms related
to orthostatic intolerance. Additionally, due to the potential influence on the autonomic nervous
system, healthy participants were excluded if they fell under any one of the following categories:
i) pregnant or lactating females, ii) clinically significant coronary artery disease, iii) concomitant
therapy with anticholinergic, alpha- and beta-adrenergic antagonists or other medications which
could interfere with autonomic functioning, and iv) failure of other organ systems or systemic
illness that could affect autonomic function or participants’ ability to cooperate. The patient
cohort was comprised of patients referred to the Autonomic Disorder Laboratory (Department of
Clinical Neurological Science, University Hospital, LHSC, London, Canada) for consultation
regarding autonomic dysfunction and/or orthostatic intolerance between September 1, 2016,
through April 30, 2018. Additional exclusion criteria for completion of the questionnaires
included individuals with communication difficulties, including those who require translation,
are illiterate, have trouble understanding and/or producing speech. To have a representative
sample size and thus improve the generalizability of the symptom scores, we collected data in a
total of 132 patients and 73 healthy controls. All study participants underwent standard
autonomic testing and completed three questionnaires. In addition, patients had a neurological
examination and medical history interview. Assessments were performed by a neurologist (KK)
who independently evaluated the presence or absence of orthostatic symptoms. Based on a
comprehensive clinical evaluation, each patient was categorized as either “Orthostatic
Intolerance” (OI) or “Non-orthostatic Intolerance” (Non-OI). Ethical approval for this study was
obtained from the Health Sciences Research Ethics Board at Western University and written
informed consent was obtained from all study participants.
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7.2.2

Clinical and questionnaire evaluation

All study participants underwent standard tests of autonomic function (Autonomic Reflex Screen
[ARS]) as previously described8. In brief, quantitative sudomotor axon reflex testing was
performed to provide an assessment of post-ganglionic sympathetic fiber integrity using a
QSWEAT device (WR Medical Electronics Co., Stillwater, MN). Adrenergic function was
assessed using beat-to-beat blood pressure and heart rate responses to Valsalva maneuver (VM)
performed to 40 mmHg, held for 15 seconds and Head-up Tilt (HUT) performed to 70° from the
horizontal. Prior to HUT, all individuals were supine for a minimum of 20 minutes. Following
baseline, participants were tilted for a maximum of 5 minutes, with a subsequent minimum 5minute recovery back in the supine position. Cardiovagal function was assessed using heart rate
responses to deep breathing (HRDB) at a pace of 6 cycles/min and Valsalva ratio (VR)
calculated from the VM. The composite autonomic scoring scale (CASS) was derived from the
ARS as previously described9. A total CASS score of 0 indicates no autonomic dysfunction,
whereas 1-3, 4-6 and 7-10 indicates mild, moderate and severe autonomic dysfunction,
respectively. Heart rate and blood pressure were continuously recorded using an
electrocardiography (ECG) device (Model 3000 Cardiac Trigger Monitor, IVY Biomedical
Systems, Inc., Branford, CT) and Nexfin hemodynamic monitoring system (BMEYE
Cardiovascular, Amsterdam, Netherlands), respectively. All data were recorded and analyzed
using WR Testworks™ software. Finally, all participants completed the ODSS7, Autonomic
Symptom Profile (ASP)10 and the Orthostatic Hypotension Questionnaire (OHQ)11. An
Orthostatic (sum of 22 questions) and Non-Orthostatic (sum of 11 questions) Symptom Score
was generated from the ODSS. Conditional ‘Yes/No’ questions were given a weighted value of
“1” or “0” so that an individual with no symptoms would generate a score of “0”, whereas higher
values would be indicative of more orthostatic and/or non-orthostatic symptomatology. The ASP
was analyzed using a computer algorithm to produce a subscale score related to Orthostatic
Intolerance10. Finally, a composite OHQ score was calculated as the average of the orthostatic
hypotension symptoms assessment (6 questions) and the orthostatic hypotension daily activity
scale (4 questions)11.
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7.2.3

Blinding protocol

To assess the accuracy of the ODSS in identifying patients with and without orthostatic
symptoms, and to reduce any potential for bias, all clinical and questionnaire data obtained from
the patient cohort were collected in a single-blinded fashion. Medical histories, neurological
exams and clinical evaluation of each patient were assessed independently by a neurologist
(KK). A separate researcher (JB) facilitated the completion and evaluation of each questionnaire
by the patients. The two members of the research team (KK and JB) were blinded to the
opposing assessment (i.e. the researcher assessing the questionnaire data was blinded to the
neurologist’s clinical evaluation, symptoms assessment, etc. and vice versa). The neurologist
grouped each individual patient as either ‘orthostatic’ [OI] or ‘non-orthostatic’ [Non-OI] based
on a comprehensive and multi-faceted patient evaluation. Clinical evaluation included symptom
assessment during an orthostatic challenge (head-up tilt) as well as information gathered via
thorough medical histories. For example, patient classification was determined based specifically
on symptoms that were always related to a change in position, without any associated supine
symptomatology. The other member of the research team (JB) performed a receiver operating
characteristic (ROC) curve analysis to assess sensitivity and specificity and to determine cut-off
scores. Based on a sensitivity and specificity of 80% and 86%, respectively, an orthostatic
symptom score of 33.5 was denoted as the cut-off score for orthostatic symptoms. Therefore, if a
patient received a score greater than 33.5, this was marked with a “1” denoting the presence of
orthostatic symptoms and if patients scored less than 33.5 this was marked with a “0” denoting
no orthostatic symptoms.

7.2.4

Statistical analysis

Descriptive statistics are presented as mean ± standard deviation. An ANOVA was used to
compare all measures obtained from patients with and without orthostatic symptoms and healthy
controls with a Bonferroni correction to correct for multiple comparisons. A paired t-test was
used to compare differences between standing and lying. Statistical correlations were performed
using a Spearman’s correlation coefficient. Sensitivity and specificity were evaluated using a
ROC curve analysis to provide an area under the curve and standard errors. Inter-item reliability
was assessed using Cronbach’s alpha. The positive and negative predictive power of the ODSS
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to identify orthostatic versus non-orthostatic symptomatology was assessed using a chi-square
crosstabulation [ODSS scores assessment X neurologist symptom assessment]. An alpha level of
0.05 was used to denote significance. All statistical analyses were performed using SPSS®
statistical software version 21 for Windows (SPSS, Inc., Chicago, IL).

7.3

Results

Participant characteristics, ARS and questionnaire data in healthy controls, OI patients and NonOI patients are presented in Table 7.1 and 7.2. Furthermore, Table 7.3 presents a breakdown of
the diagnoses and male to female ratio in the OI group. In the current study, patients were
categorized as idiopathic NOH if there was considerable orthostatic hypotension without an
appropriate compensatory postural tachycardia, along with evidence of other questionable
phenomenon (i.e. gastrointestinal issues, olfactory impairment, etc.), while not meeting criteria
for other alpha-synucleinopathies. As such, the latter diagnosis may be clearer over time as
patients can develop a more specific diagnosis. In contrast, patients were categorized as PAF if
they had maintained a purely peripheral autonomic failure without any evidence of other
pathologies for an extended period of time. A diagnosis of OI was given provided the patient had
clear and specific postural symptomatology without meeting criteria for the other categories
described. As is the case with idiopathic NOH, a more specific diagnosis may develop over time.

7.3.1

Autonomic reflex screen

Controls had significantly higher heart rate responses to deep breathing compared to patients
with OI (p<0.001) and significantly larger Valsalva ratios compared to both OI (p<0.001) and
Non-OI (p=0.02) patients. Similarly, controls had significantly lower resting heart rates
compared to both patient groups (OI: p<0.001; Non-OI: p=0.002) and significantly lower resting
systolic blood pressures compared to OI patients (p=0.004). On head-up tilt, both controls and
Non-OI patients had significantly smaller blood pressure drops compared to patients with OI
(p<0.001). Overall, OI patients scored significantly higher on all three indices of the CASS
compared to both control and Non-OI patients (p<0.001) (Table 7.1).
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7.3.2

Questionnaire data

All three groups produced significantly different scores on the ODSS – Orthostatic score, the
composite OHQ score and the Orthostatic Index of the ASP. The general trend across all three
questionnaires was that patients with OI scored the highest, followed by patients without OI,
followed by healthy controls scoring the lowest. In contrast, for the ODSS – Non-orthostatic
score, patients with and without orthostatic intolerance scored significantly higher than healthy
controls; however, there were no significant differences between the two patient groups (Table
7.2). However, there were significant differences when the symptoms were broken down into
“standing” versus “lying”. In the standing position, fatigue and weakness were significantly
different across all three groups (p<0.001), whereas pain in the standing position was not
different between patient groups. Furthermore, in the lying position, there were no significant
differences between orthostatic and non-orthostatic patients (pain, p=0.5; fatigue, p=1.00;
weakness, p=0.7). Controls scored significantly lower in all three symptoms in both the lying and
standing position (p<0.001). Subsequent paired analysis comparing symptoms in the lying versus
standing position revealed that in the orthostatic intolerance group, patient reports of pain,
fatigue and weakness significantly decreased from standing to lying (p<0.001). In the nonorthostatic patient group, fatigue and weakness showed similar significant reductions with
position change (p<0.001). However, there were no significant change in reported pain (p=0.8).
Controls showed no significant symptom changes associated with position (Figure 7.2). Finally,
total CASS correlated significantly with both the Orthostatic (r=0.395; p<0.001) and NonOrthostatic (r=0.311; p<0.001) symptom scores of the ODSS.

7.3.3

Sensitivity and specificity

The ROC curve analysis of the ODSS – Orthostatic symptom score showed an equivalent
sensitivity and specificity to that of the ASP and the OHQ (Figure 7.1). The area under the curve
(AUC) for the ODSS – Orthostatic score, Non-Orthostatic score, OHQ and ASP were: 0.89,
0.79, 0.88, and 0.91, respectively. As previously describes, a cut-off score was determined based
on the data produced from the ROC curve. Based on the ANOVA data, only an orthostatic
symptom score was used as a cut-off, as the non-orthostatic symptom score was not significantly
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different between OI and Non-OI patients. An Orthostatic cut-off score of 33.5 was used in the
sub-analysis based on a predicted yield of 80% sensitivity and 86% specificity.

7.3.4

Evaluation of predictive power

Based on the ROC curve analysis, the cut-off score of 33.5 was applied to a subset of 100
patients to calculate the positive and negative predictive powers. A subset of 100 patients was
used in the blinded analysis based on the minimum recommended number for obtaining a sample
size with a normal distribution. A chi-square crosstabulation between ODSS assessment and
clinical outcome revealed a positive predictive power of 73% (n=43/59) and a negative
predictive power of 81% (n=33/41). Additionally, there were n=16 false positives and n=8 false
negative (Total patients: 100). Combined, the ODSS appropriately identified those patients with
and without orthostatic symptoms with a 76% accuracy.

7.3.5

Inter-item reliability

A reliability assessment of all dichotomous (Yes/No) questions pertaining to the orthostatic and
non-orthostatic symptom scores was assessed using Cronbach’s alpha. Cronbach’s alpha for the
orthostatic and non-orthostatic symptom scores were 0.85 and 0.85, respectively. For the
orthostatic score, it was determined that question pertaining to, Q: “morning symptoms” and Q:
“prolonged standing” correlated the highest to the overall questionnaire score, whereas Q: “postprandial symptoms” correlated the least. However, in an inter-item reliability assessment, all
items appeared worthy of retention, resulting in a decreased alpha if deleted. For the nonorthostatic symptom score, Q: “fatigue while standing” correlated the strongest with the
symptom score and Q: “light-headedness and dizziness while lying” correlated the least.
However, similar to the orthostatic score, all items appeared worthy of retention, resulting in a
decreased alpha if deleted. When all items were considered together the test yielded a
Cronbach’s alpha of 0.88, indicative of strong internal consistency. Further evaluation revealed
that all items appeared worthy of retention, resulting in a decreased alpha if deleted.
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Table 7.1 Participant questionnaire data
Control
mean±SD

Orthostatic
Intolerance
mean±SD

Non-Orthostatic
Intolerance
mean±SD

ODSS
Orthostatic Score
7.8±9.7*†
47.2±17.1
25.0±21.5*
95% Confidence
5.5-10.1
43.6-50.9
18.6-31.4
Interval
Non-Orthostatic Score
1.2±2.6*†
11.7±8.5
10.4±10.7
95% Confidence
0.6-1.8
9.8-13.5
7.2-13.6
Interval
ASP – Orthostatic
3.9±5.4*†
27.8±9.6
14.0±12.1*
Index
95% Confidence
2.6-5.1
25.7-29.8
10.2-17.8
Interval
Composite OHQ score
0.13±3.0*†
4.5±2.8
1.9±2.4*
95% Confidence
0.06-0.2
3.9-5.1
1.1-2.6
Interval
*significantly different from OI patients (p<0.001); † significantly different from Non-OI
patients (p<0.001). Abbreviations: ODSS, orthostatic discriminant and severity score; ASP,
autonomic symptom profile; OHQ, orthostatic hypotension questionnaire
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Table 7.2 Summary of participant characteristics and autonomic reflex screening data
Control
Orthostatic
Non-Orthostatic
P-value
mean±SD
Intolerance
Intolerance
mean±SD
mean±SD
N=73
N=83
N=49
Age (years)
54±21
57±19
55±18
NS
Range (years)
13-88
18-88
17-88
Sex Ratio (Male:
34:39
42:41
24:25
Female)
Autonomic Reflex
Screen
QSART (µL)
Forearm
1.04±1.07
1.02±0.94
1.23±1.06
NS
Proximal Leg
1.19±1.21*
0.79±.91
0.91±0.73
*0.048
Distal Leg
1.17±1.32*
0.60±0.57
0.91±0.94
*0.001
Foot
0.99±0.88*
0.67±0.60
0.86±0.74
*0.027
Heart rate to Deep
17.4±9.2*
10.8±11.5
13.6±8.8
*<0.001
Breathing (bpm)
Valsalva Ratio
1.9±0.4*†
1.5±0.5
1.6±0.4
*<0.001
†0.02
Head-up Tilt
Resting Heart Rate
63.1±9.0*†
74.0±12.5
70.6±12.6
*<0.001
(bpm)
†0.002
∆Heart rate (bpm)
23.1±11.8
18.1±15.0
17.2±12.5
NS
Resting SBP
126.8±20.2*
140.2±30.9
132.7±23.2
*0.004
(mmHg)
∆SBP (mmHg)
-20.0±10.6*
-54.8±37.5
-16.9±14.3*
*<0.001
CASS
Sudomotor Index
0.28±0.76*
0.87±1.16†
0.43±0.82
*0.001
†0.046
Cardiovagal Index
0.08±0.58*
1.17±1.05
0.38±0.66*
*<0.001
Adrenergic Index
0.14±0.12*
2.5±1.90
0.4±1.16*
*<0.001
Total CASS
0.36±0.83*
1.45±3.36
1.24±1.96*
*<0.001
*significantly different from OI patients; † significantly different from Non-OI patients.
Abbreviations: QSART, quantitative sudomotor axon reflex test; µL, microliters; bpm, beats
per minute; mmHg, millimeters of mercury; SBP, systolic blood pressure; CASS; Composite
autonomic scoring scale; NS, non-significant

129

Table 7.3 Breakdown of Orthostatic Intolerance patient group
Diagnosis MSA PAF PD+NOH Idiopathic DAN AAG POTS Syncope
NOH
Sample
6
3
16
21
10
2
16
4
Size
M:F ratio
5:1
1:2
9:7
14:7
7:3
1:1
2:14
1:3

OI
5
2:3

Abbreviations: MSA, Multiple system atrophy; PAF, Pure autonomic failure; PD+NOH,
Parkinson’s Disease + Neurogenic orthostatic hypotension; NOH, Neurogenic orthostatic
hypotension; DAN, Diabetic autonomic neuropathy; AAG, Autoimmune autonomic
ganglionopathy; POTS, Postural orthostatic tachycardia syndrome; OI, Orthostatic Intolerance;
M, Male; F, Female.
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A)

B)

C)

Figure 7.1 Comparison of constitutional symptoms in controls and patients, lying and standing
Pain (A), fatigue (B) and weakness (C) standing and lying in patients with and without orthostatic intolerance and healthy controls. Patients with
orthostatic intolerance show a significant reduction in reported symptoms from standing to lying. Patients without orthostatic intolerance show a
significant reduction in reported fatigue and weakness (p<0.001), but not pain (p=0.8). Controls show no significant changes relative to position.
*significant difference between standing and lying (p<0.001).
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A) ODSS ROC Curve

B) OHQ ROC curve

C) ASP ROC Curve

AUC:
Orthostatic Curve: 0.90
SE: 0.02; 95% CI: 0.85-0.94
Non-Orthostatic Curve: 0.80
SE: 0.03; 95% CI: 0.73-0.86

AUC: 0.88
SE: 0.03; 95% CI: 0.82-0.93

AUC: 0.91
SE 0.02; 95% CI: 0.87-0.95

Figure 7.2 Receiver operating characteristic (ROC) curves for the symptom scores
ROC curves for A) Orthostatic Discriminant and Severity Score (ODSS) show strong and comparable sensitivity
and specificity measures to that of the B) Composite Orthostatic Hypotension Questionnaire (OHQ), and C)
Autonomic Symptoms Profile (ASP) – Orthostatic Index. Abbreviations: AUC, area under the curve; SE, standard error;
CI, confidence interval.
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7.4

Discussion

The primary objective of the current study was to assess the ability of the Orthostatic
Discriminant and Severity Scale (ODSS) to distinguish symptoms of orthostatic intolerance from
non-orthostatic symptoms. Our results reveal four major findings: 1) An Orthostatic cut-off score
of 33.5 provided a strong positive and negative predictive value for accurately identifying
orthostatic symptoms. 2) Both Orthostatic and Non-orthostatic symptom scores were capable of
distinguishing the patient cohorts. 3) Evaluation of the AUC for the ODSS – Orthostatic
symptom scores yielded results similar to that of previously validated tools for symptom
assessment. 4) Cronbach’s alpha for the questionnaire demonstrated strong internal consistency
and an inter-item reliability assessment showed that all dichotomous questions were worthy of
retention.
Several questionnaires focused on diverse patient populations such as Diabetic Autonomic
Neuropathies, Multiple System Atrophy, Parkinson’s Disease and generalized autonomic failure
do exist12–14. However, the majority of these questionnaires target the presence of symptoms
and/or assessment of symptom burden. Additionally, few questionnaires address the non-specific
symptoms, such as fatigue, weakness and pain, and most relevant, none discriminate these
symptoms as being either orthostatic or non-orthostatic. The ODSS is unique in that it was
designed to help identify and discriminate non-specific symptoms such as lightheadedness,
dizziness, weakness, fatigue, etc., as being either orthostatic or non-orthostatic. In clinical
settings, these symptoms can often overlap with other non-specific etiologies, and therefore
accurate identification can be difficult. There was a significant difference in the orthostatic
scores between healthy controls, patients assessed as having orthostatic symptoms and patients
assessed as having non-orthostatic symptoms by a neurologist. This indicates the ODSS –
orthostatic symptom score has the ability to distinguish between these three groups. Furthermore,
the results of the single-blinded assessment found the ODSS – orthostatic symptom score was
capable of identifying patients with orthostatic symptoms with 73% accuracy, and appropriately
identified patients without orthostatic symptoms with an 81% accuracy rating.
In contrast, the assessment of non-orthostatic symptoms such as pain, fatigue and weakness did
not significantly differ between patients with and without orthostatic symptoms, but rather
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between patient groups and healthy controls. However, this result is not surprising as patient
symptoms are not reliably distinguishable, and often have considerable overlap. For example, in
the current study we evaluated pain as a non-specific, non-orthostatic symptom. However,
certain types of pain (i.e. coat-hanger pain) can be orthostatically-mediated. Therefore, when
evaluated separately on the basis of position, two interesting results were identified. First, all
three groups were significantly different when symptoms of fatigue and weakness were assessed
in the standing position. Second, patients with orthostatic intolerance reported significant
symptom reduction across all three symptoms when there was a change in position from standing
to lying. In contrast, in the non-orthostatic patient group, reports of pain did not significantly
change with position. Finally, total CASS was significantly correlated with both orthostatic and
non-orthostatic symptom scores, suggesting the presence of orthostatic and non-orthostatic
symptomatology correlate with severity and distribution of autonomic dysfunction. However,
these correlations are beginning to show evidence of divergence, and it will be of interest to see
how these relationships evolve with the recruitment of additional clinical populations, as well
when evaluated within discrete homogenous patient groups. Nonetheless, at present these
findings, combined with the results of the orthostatic symptom score, may help to reliably
distinguish patients with and without orthostatic intolerance.
Accurately identifying and distinguishing patients with and without orthostatic intolerance has
many important clinical implications, some of which include, earlier access to specialized care,
reduced risk for potential serious injury related to falls, and proper adjustments to treatments for
symptom management.
Orthostatic symptoms are the primary cause of morbidity in patients with generalized autonomic
dysfunction. However, application of both conservative and pharmacological measures has been
shown to effectively reduce orthostatic symptoms and disease burden15,16. Therefore, the ability
to accurately identify patients with orthostatic symptomatology would not only help to improve
the streamlining of patients but would also facilitate the process by which symptom management
techniques can be acquired sooner.
Additionally, accurate identification of symptoms can help reduce fall risks associated with
concomitant medications. For example, patients with Neurogenic Orthostatic Hypotension
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secondary to autonomic failure can also have profound hypertension while seated and/or lying
flat6. As office blood pressure measurements are commonly not taken while a patient is standing,
these results often lead to a prescribed anti-hypertensive agent that will severely exacerbate their
blood pressure drop upon standing, and increase the likelihood of syncope. Therefore, accurately
identifying orthostatic symptoms has the potential to expose an underlying condition related to
autonomic failure and, in turn, help reduce the risk for potential serious injury related to falls.
Finally, in treating patients with orthostatic and autonomic dysfunction, treatments are often
titrated to individual symptoms. For example, in patients with NOH, the use of standard antihypotensive agents often includes supine hypertension as a side effect. If a patient’s symptoms
show improvement, it is important to appropriately titrate dosages and/or schedules to reduce the
risks associated with supine hypertension. Access to a simple instrument such as the ODSS
provides a symptom assessment to help gauge symptoms.

7.4.1

Future studies

Overall, given the large patient sample size and the methods taken to obtain a diverse and
unbiased sample, we believe the current study is representative of the patient cohort that is
typically referred to a specialist clinic for questions of autonomic dysfunction. However, further
investigation is warranted. In future studies we aim to collect data in another 100 patients to reassess the positive and negative predictive powers within a larger sample size. Second, we aim to
combine all data to quartile the scores to formulate a scale of symptom severity, including: No
symptoms, mild, moderate and severe symptoms. Third, in a longitudinal study, we are currently
collecting data to measure how symptoms change over time, and how these symptoms correlate
with standard measures of autonomic function. Fourth, we aim to separate different patient
groups to assess the sensitivity and specificity within smaller homogenous patient groups. This
fourth aim will also include patient groups who may be more likely to have higher degrees of
non-orthostatic symptoms such as chronic fatigue syndrome or fibromyalgia. Finally, with larger
sample sizes, we will also be able to re-evaluate the reliability and internal consistency of each
question within discrete patient cohorts, which will enable us to pars out which questions are
worthy of retention within individual clinical populations. Our ultimate goal is to make the
ODSS easily available in an online format with immediate score generation.
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7.4.2

Study limitations

The ODSS has demonstrated a strong ability to identify patients with and without orthostatic
intolerance with a relatively high accuracy. Additionally, the items of the questionnaire have
yielded strong inter-item reliability and the ODSS – orthostatic score showed strong sensitivity
and specificity similar to that of other validated tools. Despite these promising results the current
study contains the following limitations: 1) Orthostatic intolerance as a result of autonomic
dysfunction can encompass a large and diverse group of patients. In the present study, we
enrolled new patients referred to the clinic without prior knowledge of the reason for referral.
Due to the methodological approach, the patient sample was extremely diverse. In future
assessments we aim to investigate the sensitivity of the ODSS in discrete patient cohorts. 2) In
the present study, the sensitivity of the ODSS to track patients’ symptoms over time and with
treatment was not evaluated. Therefore, longitudinal studies, as well as implementation within a
clinical trial need to be done to address this aspect of the ODSS.

7.5

Conclusion

In the current study, the ODSS demonstrated a strong ability to distinguish between patients with
and without orthostatic intolerance based not only on the absolute orthostatic symptom score, but
also in a blinded assessment, which yielded strong positive and negative predictive power values.
Furthermore, the symptom scores of the ODSS demonstrated a sensitivity and specificity
equivalent to that of other standardized measures. Finally, a reliability analysis yielded a
Cronbach’s alpha that showed the ODSS reached an acceptable reliability, and all items were
deemed worthy of retention. Overall, the ODSS produces symptom scores that are both reliable
and useful for both research and clinical practice to aid in the distinction of orthostatic versus
non-orthostatic symptomatology.
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CHAPTER 8

8

General Discussion and Summary

8.1

General Discussion

In these studies, I aimed to improve our understanding and assessment of neurogenic
orthostatic hypotension (NOH) related to autonomic failure. This thesis provided novel and
unique findings related to this overall objective. The first portion of this thesis was designed to
improve our understanding of the pathophysiology contributing to NOH. Specifically, whether
patients demonstrated altered activation within the central autonomic network during autonomic
challenges. The first set of results (Chapters 2 & 4) support this hypothesis as the results
revealed, 1) patients had reduced cortical and sub-cortical autonomic network activation during
sympathetically-mediated challenges and 2) patients had reduced brainstem functional
connectivity both at rest and during autonomic maneuvers. Of interest, patients also
demonstrated reduced cerebellar activity and reduced cerebellar connectivity (Chapters 3 & 5).
This was of particular interest as the cerebellum integrates vestibular, spinal and brainstem
afferents in response to postural changes and subsequently influences descending inputs to
vestibulosympathetic pathways. For example, in response to standing and/or head-up tilt the
cerebellum is involved in mediating an early sympathetic reflex to facilitate vasoconstriction,
which contributes to postural control of blood pressure in the upright position. This is relevant to
the clinical population as the inability to maintain adequate blood pressure in the standing
position is the definition of NOH. Furthermore, studies have shown that cerebellar
dysfunction/insult not only results in orthostatic hypotension but also affects postural symptoms
such as lightheadedness and dizziness.
Therefore, the second part of this thesis focused to improve our ability to identify and to assess
patients on the basis of orthostatic symptomatology, which can be indicative of autonomic
dysfunction. Symptoms such as dizziness and lightheadedness are some of the most common
clinical descriptions and remain an independent predictor of increased mortality after adjusting
for factors such as age, race, ethnicity, sex and disease1,2. These symptoms can be very
generalized, but they can also be very specific to postural adjustments as one changes position
from lying or sitting to standing. When these symptoms are not properly assessed, accurate

139

identification and diagnosis can be challenging. Therefore, we devised a self-report questionnaire
(the Orthostatic Discriminant and Severity Scale [ODSS]) capable of identifying and
discriminating orthostatically mediated symptoms. I found that patients reported significant
orthostatic symptomatology that correlated with autonomic dysfunction and orthostatic blood
pressures (Chapter 6). I also found the ODSS is capable of identifying and discriminating
patients with and without orthostatic symptomatology related to autonomic dysfunction (Chapter
7).
These findings (1) build upon the current understanding of the central autonomic network and
the human cerebellum and how they contribute to proper autonomic control; (2) provide
evidence of cerebellar impairment in autonomic failure, which may indicate a new mechanism
underlying both impaired orthostatic blood pressure regulation and orthostatic symptomatology,
including postural lightheadedness and dizziness and (3) provide a new validated tool for
assessing postural symptomatology related to autonomic dysfunction.
The concept of a central autonomic network (CAN) involving cortical, subcortical and brainstem
structures has been well established3. Certainly, an abundance of research has investigated
regions of the human CAN and delineated specific structures to various functions. For example,
in healthy individuals functional imaging studies have identified discrete neurocircuitry
associated with reflex cardiovascular control during sympathetically-mediated challenges (i.e.
Valsalva maneuver, handgrip, lower body negative pressure), including the insular cortex,
thalamus, anterior cingulate cortex, cerebellum, amygdala and hippocampus4–9.
Macefield and Henderson extended this work by using concurrent microneurography recordings
of sympathetic nerve activity and functional imaging. This work revealed that increased activity
in the anterior insular cortex, anterior cingulate cortex and cerebellum corresponded with
increased sympathetic activity10,11. Studies have also used clinical models such as localized
strokes to investigate the effect of cortical lesions on autonomic responses12. The results of
Chapter 2 are novel in that they provide a unique clinical model of sympathetic failure that
corroborates the current literature regarding functional contributions of CAN structures. In this
chapter I found that patients with sympathetic dysfunction or failure have reduced activity in the
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same central sites implicated in sympathetic outflow including the anterior cingulate cortex,
hippocampus, thalamus and cerebellum.
Beyond basic autonomic physiology, the results contained within the first half of this thesis
(Chapters 2-5) also offer new insights into the understanding of the pathophysiology of
autonomic failure. The results suggest additional pathophysiology in NOH that extends beyond
efferent sympathetic dysfunction. The results of Chapter 2 implicate higher forebrain
involvement; meanwhile the results contained within Chapter 4 show evidence of reduced
connectivity between the brainstem and cortical/subcortical structures in autonomic failure
patients.
As previously discussed, several important brainstem nuclei facilitate beat-to-beat control of
arterial blood pressure (BP) through the arterial baroreflex13. Anatomical connections between
brainstem nuclei and cortical/subcortical networks have been well established, and functionally,
these cortical and subcortical structures (already described herein) contribute feed-forward
signals for additional regulation of cardiovascular and autonomic reflexes. Evidence of reduced
functional connectivity between these two fundamental autonomic networks contributes novel
information to clinical autonomic research.
Importantly, Chapters 3 & 5 build upon and provide additional support regarding an important
role for the human cerebellum in autonomic functioning. While this concept is not new, the
current results are novel and interesting in the context of the patient group because 1) damage to
the cerebellum results in impaired postural control of blood pressure14–16 – the same dysfunction
experienced by patients with NOH, and 2) cerebellar dysfunction contributes to postural
lightheadedness, dizziness and orthostatic intolerance2,17 – the same symptomatology
experienced by these patients.
Regions of the cerebellum, namely the vermis, posterior lobule 9 and the deep cerebellar nuclei,
demonstrate significant functional overlap in both baroreceptor and vestibular sympathetic
reflexes18–20. In response to postural adjustments to an upright position, both reflexes send
afferent projections that converge at the level of the RVLM, with measurable increases to
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peripheral sympathetic nerve activity18,19,21–24. Together, both reflexes facilitate vasoconstriction,
blood redistribution and ultimately help maintain blood pressure while upright.
Importantly, Chapter 3 revealed that patients with NOH showed significantly reduced activation
within the cerebellum during blood pressure perturbations facilitated by VM and LBNP. To
extend these findings, I investigated functional connectivity specifically within the cerebellum
(Chapter 5). The findings revealed that patients with NOH had reduced functional connectivity in
the same regions shown to contribute to increased sympathetic outflow, including the vermis and
posterior lobule 9. Interestingly, cerebellar connectivity was reduced to several important regions
including the brainstem and central autonomic structures and this was evident both at rest and
during an autonomic challenge (LBNP and VM).
Finally, the second half of this thesis focused on symptomatology related to NOH and autonomic
dysfunction. NOH patients can often present with various orthostatic symptoms such as postural
lightheadedness, dizziness, faintness, etc. These symptoms are a major cause of morbidity,
reduce the ability to live independently and can greatly decrease quality of life1,25,26. Recognizing
and appropriately discriminating the postural component of these symptoms is imperative for
proper diagnosis and treatment. The Orthostatic Discriminant and Severity Scale (ODSS) was
designed to help make this important distinction to identify and assess patients on the basis of
their symptoms. Chapter 6 provides promising preliminary evaluation of the ODSS in the context
of validity and reliability. The results of Chapter 7 showed strong sensitivity and specificity of
the ODSS and importantly, demonstrated that the ODSS was capable of accurately identifying
patients with and without autonomic dysfunction solely based upon a symptom assessment.
Given the degree of widespread impairment that can accompany autonomic dysfunction and the
availability of both pharmacological and conservative measures to help mitigate orthostatic
symptoms, early diagnosis will be pivotal to improve quality of life, extend independent living
and reduce risk of falls.
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8.1.1

Overall study limitations

fMRI is a widely used and accepted technique in the field of autonomic research to discern
functional contributions of central structures to autonomic control. However, it is important to
acknowledge that the use of functional imaging as a modality for understanding brain
mechanisms is primarily limited to the underlying assumption that BOLD signal changes
represent neural changes. It is important to note that the BOLD signal does not isolate nor
directly measure neuronal activity. The BOLD signal is a surrogate signal for brain function
reflecting changes in the ratio between oxygenated and deoxygenated hemoglobin.
Despite this assumption, the findings and the brain regions reported in the current set of studies
are consistent with existing autonomic literature3,6,27. Importantly, the regions discussed
including the cerebellum, cingulate, insula, hippocampus, etc. are strongly supported in
autonomic and functional imaging literature, as well by studies that have used different
modalities other than imaging including, clinical models (i.e. stroke), electrical and chemical
stimulation, ablation, etc.
In the connectivity analysis, the use of cortical and subcortical atlases can be limiting.
Specifically, application of a brainstem mask covering the whole brainstem cannot isolate
discrete nuclei. Structurally and functionally, the brainstem is extremely diverse and therefore
the current results would be improved if individual nuclei could be isolated. Unfortunately, the
current program used to analyze the connectivity data set this limitation. The functional
connectivity program currently available for a regions-of-interest analysis uses a whole
brainstem mask to determine brainstem connectivity. Further investigation into discrete
brainstem nuclei is certainly warranted. Despite this limitation the current results are still unique
revealing that patients with autonomic failure have reduced brainstem connectivity, and
importantly reduced connectivity to regions strongly supported in autonomic control.
Despite the aforementioned limitations surrounding functional imaging and functional
connectivity, I remain confident in the current findings pertaining to activation of autonomic
structures and their functional connections to other structures that make up the central autonomic
network.
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The primary limitation of the results contained in the second half of this thesis pertains to the
heterogeneous sample of patients used in the early stages of developing the ODSS. This
approach was primarily chosen based on methodological considerations. For example, during the
blinded study all patients needed to be included as opposed to specific clinical groups (i.e. NOH)
otherwise, there would in essence be no blinding. Moving forward, I believe the ODSS will be
most suitable and accurate for clinical groups with NOH. However, until there is sufficient data
to support this conclusion, we continue to recruit all patient groups with orthostatic intolerance
related to autonomic dysfunction.

8.1.2

Future studies

The current thesis provides the foundation for a number of important and interesting directions
for future research. Future studies may continue to build upon the cross-link between the
cerebellum and autonomic dysfunction and the cerebellum in postural symptomatology.
An important consideration when evaluating orthostatic symptoms is that it can be quite common
for patients to report no symptoms even when there is clear clinical evidence of severe OH. In a
study of 105 Parkinson’s patients who met the clinical criteria for NOH, only 13% reported to be
symptomatic28. Some efforts have been made to determine which factors contribute to postural
symptoms. For example, does symptomatology depend on absolute blood pressure changes or
how low blood pressure goes?28 Another hypothesis is that some disorders related to autonomic
failure can progress very slowly, and as such, patients become acclimated to blood pressure falls
over time. The current thesis may lend support for an alternative hypothesis regarding autonomic
dysfunction and postural symptomatology related to differences in cerebellar impairment (Figure
8.1). For example, do patients with NOH and autonomic failure with evidence of cerebellar
impairment report more profound postural symptoms?
In a 2016 consensus statement regarding the signs and symptoms of cerebellar dysfunction, brief
occurrences (seconds-minutes) of cerebellar dizziness induced by positional changes were
evident in cerebellar lesions affecting the posterior cerebellum and vermis29. Furthermore, one
study found that 31% of patients with acute cerebellar infarctions revealed adrenergic
sympathetic dysfunction evidenced by orthostatic hypotension on head-up tilt (-37mmHg drop),
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absent adrenergic phases in response to Valsalva maneuver and 28% reported orthostatic
dizziness on standing17. Furthermore, evidence shows that patients with autonomic failure have
impaired baroreflex functioning. Additionally, the cerebellum has direct and indirect projections
that feed into both the baroreflex and vestibulo-sympathetic reflex pathways. Therefore, an
interesting avenue of future research would be to further investigate cerebellar and vestibulosympathetic reflexes in patients with NOH (Figure 8.1). This could be accomplished using direct
transcranial magnetic stimulation (TMS) of the cerebellum or through galvanic vestibular
stimulation (GVS). Either TMS or GVS could be applied at rest and during an orthostatic
challenge while measuring autonomic/hemodynamic responses. Furthermore, cerebellar
stimulation and/or activation of cerebellar reflexes with concurrent functional imaging would
build upon the current findings. This, in conjunction with investigation into discrete brainstem
nuclei including baroreceptor nuclei and vestibular nuclei in autonomic failure would be an
interesting area for future research.
Regarding the ODSS, there are plenty of additional studies that would continue to improve and
develop this tool. First, any questionnaire devised for clinical use, or otherwise, requires large
samples sizes and continuous monitoring and adjustments to optimize its potential. Therefore,
ongoing recruitment and evaluation of the ODSS to continue to assess and improve the
sensitivity and specificity should be an area of future research. Moreover, the sensitivity and
specificity of the ODSS should be tested within discrete clinical groups to better understand
where this tool may be best applied (i.e. autonomic failure, postural tachycardia, syncope, etc.).
Second, to evaluate the ability of the ODSS to detect changes in symptoms, a longitudinal study
of patients with autonomic dysfunction is required. For example, patients could be monitored
over time to assess changes in reported symptoms and whether or not these changes are
associated with any physiological parameter (i.e. blood pressure, distribution of autonomic
dysfunction, heart rate, etc.). Additionally, longitudinal symptom assessment could be applied to
monitor responsiveness to medication. This information would be extremely helpful when
determining medication dosages and scheduling to best target orthostatic symptoms.
Alternatively, the ODSS could be used within a clinical trial where symptoms can be assessed in
response to pharmacological intervention.
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Ideally, all autonomic and ODSS data obtained from various clinical cohorts, along with healthy
normative individuals should be combined to generate a database containing a range of symptom
severities from no orthostatic symptoms (obtained from normative database) to severe
orthostasis, possibly indicative of autonomic dysfunction (obtained from clinical samples).
Finally, the overall goal of the ODSS should be to have it available to clinicians to help
discriminate non-specific symptoms.

8.2

Summary

The results contained in the first half of this thesis build upon the foundation of knowledge
surrounding the current understanding of the central autonomic network and the contributions of
discrete cortical and subcortical structures in autonomic functioning. The novelty of the current
thesis lies in its potential clinical impact regarding the understanding and assessment of NOH
related to autonomic failure. Specifically, reduced activation in central autonomic structures
along with reduced functional connectivity between the brainstem and central autonomic
structures have not been previously investigated in patients with NOH related to autonomic
failure. These findings add to the current understanding of pathophysiological mechanisms
contributing to autonomic dysfunction and NOH. In addition, the findings surrounding reduced
cerebellar activation and reduced cerebellar connectivity to the brainstem and central autonomic
structures provide novel insight into the potential role of the human cerebellum in autonomic
dysfunction (Chapters 3 & 5). The latter half of this thesis (Chapters 6 & 7) will have a direct
clinical contribution to early identification of patients with NOH related to autonomic
dysfunction based on symptom assessment. Overall, these studies build upon current autonomic
research and provide a foundation that may help direct future research geared toward improving
clinical assessment and understanding of NOH related to autonomic dysfunction.
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Figure 8.1 Proposed model of cerebellar integration in autonomic control, autonomic failure
and postural symptomatology.
The cerebellum is established as a central component of both the vestibulo-sympathetic reflex
and postural symptomatology. Therefore, future studies should investigate: 1) Whether
patients with NOH and autonomic failure show impaired vestibulo-sympathetic reflexes,
which may further contribute to reduced sympathetic responses while upright. 2) Whether
cerebellar impairments in NOH patients correlate with the presence and/or severity of postural
symptoms.
Cerebellum graphic: https://icm-institute.org/en/actualite/channels-strike-again-a-commonbattle-for-axatias-and-epilepsy/
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